A family of symporters that facilitate sodium-dependent membrane transport of phosphate.
A family of sodium-phosphate cotransporter proteins with eight transmembrane domains. They are present primarily in the KIDNEY and SMALL INTESTINE and are responsible for renal and small intestinal epithelial transport of phosphate.
An electrogenic sodium-dependent phosphate transporter. It is present primarily in BRUSH BORDER membranes of PROXIMAL RENAL TUBULES.
A family of sodium-phosphate cotransporter proteins that also transport organic ANIONS. They are low affinity phosphate transporters.
A non-electrogenic sodium-dependent phosphate transporter. It is found primarily in apical membranes of PROXIMAL RENAL TUBULES.
Membrane transporters that co-transport two or more dissimilar molecules in the same direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is "powered" by the movement of another ion or molecule with its electrochemical gradient.
A condition of an abnormally low level of PHOSPHATES in the blood.
A sodium-dependent phosphate transporter present primarily at apical sites of EPITHELIAL CELLS in the SMALL INTESTINE.
A family of highly conserved and widely expressed sodium-phosphate cotransporter proteins. They are electrogenic sodium-dependent transporters of phosphate that were originally identified as retroviral receptors in HUMANS and have been described in yeast and many other organisms.
Inorganic salts of phosphoric acid.
A subclass of symporters that specifically transport SODIUM CHLORIDE and/or POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process.
Agents that are used to stimulate evacuation of the bowels.
A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
Transport proteins that carry specific substances in the blood or across cell membranes.
New World marsupials of the family Didelphidae. Opossums are omnivorous, largely nocturnal and arboreal MAMMALS, grow to about three feet in length, including the scaly prehensile tail, and have an abdominal pouch in which the young are carried at birth.
Minute projections of cell membranes which greatly increase the surface area of the cell.
A hereditary disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; renal defects in phosphate reabsorption and vitamin D metabolism; and growth retardation. Autosomal and X-linked dominant and recessive variants have been reported.
The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE.
A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
A plasma membrane exchange glycoprotein transporter that functions in intracellular pH regulation, cell volume regulation, and cellular response to many different hormones and mitogens.
Endoscopic examination, therapy or surgery of the luminal surface of the colon.
Proteins that cotransport sodium ions and bicarbonate ions across cellular membranes.
A subclass of symporters found in KIDNEY TUBULES, DISTAL that are the major pathway for salt resorption. Inhibition of these symporters by BENZOTHIADIAZINES is the basis of action of some DIURETICS.
Na-K-Cl transporter ubiquitously expressed. It plays a key role in salt secretion in epithelial cells and cell volume regulation in nonepithelial cells.
The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.
The washing of a body cavity or surface by flowing water or solution for therapy or diagnosis.
Preparations of Cassia senna and C. angustifolia (see SENNA PLANT). They contain sennosides, which are anthraquinone type CATHARTICS and are used in many different preparations as laxatives.
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION.
A sulfamyl diuretic.
Na-K-Cl transporter in the ASCENDING LIMB OF LOOP OF HENLE. It mediates active reabsorption of sodium chloride and is inhibited by LOOP DIURETICS such as FUROSEMIDE; and BUMETANIDE. Mutations in the gene encoding SLC12A1 are associated with a BARTTER SYNDROME.
Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.
Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.
Agents used to prevent the formation of foam or to treat flatulence or bloat.
A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.
Na-Cl cotransporter in the convoluted segments of the DISTAL KIDNEY TUBULE. It mediates active reabsorption of sodium and chloride and is inhibited by THIAZIDE DIURETICS.
The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
An inherited condition of abnormally low serum levels of PHOSPHATES (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the PROXIMAL RENAL TUBULES. This leads to phosphaturia, HYPOPHOSPHATEMIA, and disturbances of cellular and organ functions such as those in X-LINKED HYPOPHOSPHATEMIC RICKETS; OSTEOMALACIA; and FANCONI SYNDROME.
A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.
A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.
Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.
A group of compounds that are monomethyl derivatives of pyridines. (From Dorland, 28th ed)
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
The rate dynamics in chemical or physical systems.
Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.
Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.
A ubiquitous sodium salt that is commonly used to season food.
An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)
Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.
A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.
'Sugar phosphates' are organic compounds that consist of a sugar molecule linked to one or more phosphate groups, playing crucial roles in biochemical processes such as energy transfer and nucleic acid metabolism.
Phlorhizin is a non-transportable glucose analog that inhibits the sodium-glucose cotransporter 1 (SGLT1) and aldohexose transporter (GLUT2), leading to reduced intestinal absorption and increased renal excretion of glucose, which is used in research to study glucose transport and diabetes-related processes.
Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
The commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.
Heterocyclic compounds with SULFUR and NITROGEN in the ring. This term commonly refers to the BENZOTHIADIAZINES that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.
The U-shaped portion of the renal tubule in the KIDNEY MEDULLA, consisting of a descending limb and an ascending limb. It is situated between the PROXIMAL KIDNEY TUBULE and the DISTAL KIDNEY TUBULE.
Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)
The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.
A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.
A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.
Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.
Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.
Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM).
The portion of renal tubule that begins from the enlarged segment of the ascending limb of the LOOP OF HENLE. It reenters the KIDNEY CORTEX and forms the convoluted segments of the distal tubule.
Agents that promote the excretion of urine through their effects on kidney function.
The movement of ions across energy-transducing cell membranes. Transport can be active, passive or facilitated. Ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions.
A family of organic anion transporters that specifically transport DICARBOXYLIC ACIDS such as alpha-ketoglutaric acid across cellular membranes.
A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is driven either directly or indirectly by a gradient of sodium ions.
A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.
The normal process of elimination of fecal material from the RECTUM.
Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.
A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis.
Elements of limited time intervals, contributing to particular results or situations.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
Monosaccharide transport proteins that function as active symporters. They utilize SODIUM or HYDROGEN IONS to transport GLUCOSE across CELL MEMBRANES.
The giving of drugs, chemicals, or other substances by mouth.

Effects of phosphate intake on distribution of type II Na/Pi cotransporter mRNA in rat kidney. (1/274)

BACKGROUND: Renal phosphate (Pi) reabsorption is regulated by dietary Pi intake, as well as in other ways. Changes in Pi reabsorption are associated with the modulation of sodium/Pi cotransporter type II (NaPi-2) protein abundance in the brush border membrane (BBM) of proximal tubules (PTs) and of renal NaPi-2 mRNA levels. In this study, we address whether the NaPi-2 protein and NaPi-2 mRNA distribution patterns in the renal cortex vary in parallel with changes of dietary Pi intake. METHODS: We investigated in cryosections of perfusion-fixed rat kidneys by in situ hybridization (ISH) and immunohistochemistry (IHC) the distribution patterns of NaPi-2 mRNA and of NaPi-2 protein one week, two hours, and four hours after changes in dietary Pi intake. RESULTS: NaPi-2 mRNA and NaPi-2 protein were present in PTs exclusively. In rats adapted to one week of high Pi intake, signals for NaPi-2 mRNA and NaPi-2 protein in cortical PTs were weak, except in the convoluted parts of PTs of juxtamedullary nephrons. After one week of low Pi intake, the ISH and IHC signals for NaPi-2 were high in PT segments in all cortical levels. The switch from a chronic high to a low Pi intake within two and four hours induced no increase and a slight increase, respectively, in the NaPi-2 mRNA signal in PTs of midcortical and of superficial nephrons, whereas in the BBM of these nephrons, NaPi-2 protein was markedly up-regulated. Two and four hours after switching from low to high Pi intake, the overall high ISH signal for NaPi-2 mRNA was unchanged, whereas NaPi-2 protein staining was drastically down-regulated in the BBM of PTs from superficial and midcortical nephrons. CONCLUSIONS: The marked changes in NaPi-2 protein abundance in the BBM, following altered dietary Pi intake, precede corresponding changes at the RNA level by several hours. Thus, the early adaptation to altered Pi intake involves mRNA-independent mechanisms. The up- or down-regulation of NaPi-2 protein abundance in the BBM and NaPi-2 mRNA in PT affects mainly midcortical and superficial nephrons.  (+info)

Regulation of PiT-1, a sodium-dependent phosphate co-transporter in rat parathyroid glands. (2/274)

A cDNA encoding an Na+-Pi co-transporter, termed rat PiT-1, has now been isolated from rat parathyroid. Expression of rat PiT-1 in Xenopus oocytes revealed that it possesses Na+-dependent Pi co-transport activity. The amount of PiT-1 mRNA in the parathyroid of vitamin D-deficient rats was reduced compared with that in normal animals, and increased markedly after administration of 1,25-dihydroxyvitamin D3. Furthermore, the abundance of PiT-1 mRNA in the parathyroid was much greater in rats fed a low-Pi diet than in those fed a high-Pi diet. Thus, rat PiT-1 may contribute to the effects of Pi and vitamin D on parathyroid function.  (+info)

Up-regulation of the Pit-2 phosphate transporter/retrovirus receptor by protein kinase C epsilon. (3/274)

The membrane receptors for the gibbon ape leukemia retrovirus and the amphotropic murine retrovirus serve normal cellular functions as sodium-dependent phosphate transporters (Pit-1 and Pit-2, respectively). Our earlier studies established that activation of protein kinase C (PKC) by treatment of cells with phorbol 12-myristate 13-acetate (PMA) enhanced sodium-dependent phosphate (Na/Pi) uptake. Studies now have been carried out to determine which type of Na/Pi transporter (Pit-1 or Pit-2) is regulated by PKC and which PKC isotypes are involved in the up-regulation of Na/Pi uptake by the Na/Pi transporter/viral receptor. It was found that the activation of short term (2-min) Na/Pi uptake by PMA is abolished when cells are infected with amphotropic murine retrovirus (binds Pit-2 receptor) but not with gibbon ape leukemia retrovirus (binds Pit-1 receptor), indicating that Pit-2 is the form of Na/Pi transporter/viral receptor regulated by PKC. The PKC-mediated activation of Pit-2 was blocked by pretreating cells with the pan-PKC inhibitor bisindolylmaleimide but not with the conventional PKC isotype inhibitor Go 6976, suggesting that a novel PKC isotype is required to regulate Pit-2. Overexpression of PKCepsilon, but not of PKCalpha, -delta, or -zeta, was found to mimic the activation of Na/Pi uptake. To further establish that PKCepsilon is involved in the regulation of Pit-2, cells were treated with PKCepsilon-selective antisense oligonucleotides. Treatment with PKCepsilon antisense oligonucleotides decreased the PMA-induced activation of Na/Pi uptake. These results indicate that PMA-induced stimulation of Na/Pi uptake by Pit-2 is specifically mediated through activation of PKCepsilon.  (+info)

Developmental expression of sodium entry pathways in rat nephron. (4/274)

During the past several years, sites of expression of ion transport proteins in tubules from adult kidneys have been described and correlated with functional properties. Less information is available concerning sites of expression during tubule morphogenesis, although such expression patterns may be crucial to renal development. In the current studies, patterns of renal axial differentiation were defined by mapping the expression of sodium transport pathways during nephrogenesis in the rat. Combined in situ hybridization and immunohistochemistry were used to localize the Na-Pi cotransporter type 2 (NaPi2), the bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2), the thiazide-sensitive Na-Cl cotransporter (NCC), the Na/Ca exchanger (NaCa), the epithelial sodium channel (rENaC), and 11beta-hydroxysteroid dehydrogenase (11HSD). The onset of expression of these proteins began in post-S-shape stages. NKCC2 was initially expressed at the macula densa region and later extended into the nascent ascending limb of the loop of Henle (TAL), whereas differentiation of the proximal tubular part of the loop of Henle showed a comparatively retarded onset when probed for NaPi2. The NCC was initially found at the distal end of the nascent distal convoluted tubule (DCT) and later extended toward the junction with the TAL. After a period of changing proportions, subsegmentation of the DCT into a proximal part expressing NCC alone and a distal part expressing NCC together with NaCa was evident. Strong coexpression of rENaC and 11HSD was observed in early nascent connecting tubule (CNT) and collecting ducts and later also in the distal portion of the DCT. Ontogeny of the expression of NCC, NaCa, 11HSD, and rENaC in the late distal convolutions indicates a heterogenous origin of the CNT. These data present a detailed analysis of the relations between the anatomic differentiation of the developing renal tubule and the expression of tubular transport proteins.  (+info)

Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2. (5/274)

PIT-2 is a type III sodium phosphate cotransporter and the receptor for amphotropic murine leukemia viruses. We have investigated the expression and the functions of a tagged version of PIT-2 in CHO cells. PIT-2 remained equally abundant at the cell surface within 6 h following variation of the phosphate supply. In contrast, the efficiency of phosphate uptake and retrovirus entry was inversely related to the extracellular phosphate concentration, indicating that PIT-2 activities are modulated by posttranslational modifications of cell surface molecules induced by phosphate. Conformational changes of PIT-2 contribute to both activities, as shown by the inhibitory effect of sulfhydryl reagents known as inhibitors of type II cotransporters. A physical association of PIT-2 with actin was demonstrated. Modifications of the actin network were induced by variations of the concentrations of extracellular phosphate, cytochalasin D, or lysophosphatidic acid. They revealed that the formation of actin stress fibers determines the cell surface distribution of PIT-2, the internalization of the receptor in response to virus binding, and the capacity to process retrovirus entry. Thus, the presence of PIT-2 at the cell surface is not sufficient to ensure phosphate transport and susceptibility to amphotropic retrovirus infection. Further activation of cell surface PIT-2 molecules is required for these functions.  (+info)

Stoichiometry and Na+ binding cooperativity of rat and flounder renal type II Na+-Pi cotransporters. (6/274)

The stoichiometry of the rat and flounder isoforms of the renal type II sodium-phosphate (Na+-Pi) cotransporter was determined directly by simultaneous measurements of phosphate (Pi)-induced inward current and uptake of radiolabeled Pi and Na+ in Xenopus laevis oocytes expressing the cotransporters. There was a direct correlation between the Pi-induced inward charge and Pi uptake into the oocytes; the slope indicated that one net inward charge was transported per Pi. There was also a direct correlation between the Pi-induced inward charge and Na+ influx; the slope indicated that the influx of three Na+ ions resulted in one net inward charge. This behavior was similar for both isoforms. We conclude that for both Na+-Pi cotransporter isoforms the Na+:Pi stoichiometry is 3:1 and that divalent Pi is the transported substrate. Steady-state activation of the currents showed that the Hill coefficients for Pi were unity for both isoforms, whereas for Na+, they were 1.8 (flounder) and 2.5 (rat). Therefore, despite significant differences in the apparent Na+ binding cooperativity, the estimated Na+:Pi stoichiometry was the same for both isoforms.  (+info)

gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate. (7/274)

BACKGROUND: For treatment of phosphate (Pi) overload in various pathophysiological states, an agent that selectively increases renal Pi excretion would be of major value. Previously, we have shown that dopamine (DA) inhibits Na(+)-Pi cotransport in renal epithelia. However, the administration of DA or its immediate precursor L-DOPA increases DA in multiple tissues. Synthetic dipeptide gamma-L-glutamyl-L-DOPA (gludopa) can serve as an inactive precursor (pro-pro-drug) of DA. This study tested the hypothesis that, because of the unique colocalization of gamma-glutamyltransferase (gamma-GT), aromatic amino acid decarboxylase, Na(+)-Pi cotransporter, and Na(+)-L-DOPA cotransporter in brush border membrane (BBM) of proximal tubular cells, gludopa may elicit phosphaturia by action of DA generated within the kidney. METHODS: Thyroparathyrectomized rats were given placebo, or gludopa, or gludopa + gamma-GT inhibitor acivicin. Urinary excretion of Pi, Ca2+, Na+, K+, DA, cAMP, and cGMP was determined, and Na(+)-Pi cotransport was measured in BBM prepared from kidneys of rats at the end of the experiment. RESULTS: The administration of gludopa resulted in: (a) an inhibition of Na(+)-Pi cotransport, but not cotransport of Na(+)-proline and Na(+)-alanine in BBM; (b) an increase (+300%) of fractional excretion (FE) of Pi and a drop (-35%) of plasma Pi, whereas the plasma levels and FEs of Ca2+, Na+, and K+ were unchanged; (c) an increase in urinary excretion of cAMP. but not cGMP; (d) a 1000-fold increase of urinary excretion of DA, without a change in excretion of norepinephrine; and (e) an incubation of gludopa with BBM in vitro, which caused a release of L-DOPA, and the in vivo administration of acivicin, which blocked actions of gludopa to inhibit Na(+)-Pi cotransport and to increase urinary excretions of Pi and DA. CONCLUSIONS: We conclude that colocalization of enzymes of biotransformation, BBM transporters, and the autocrine/paracrine DA system in cells of proximal tubules constitutes a cellular basis for the potent and specific phosphaturic action of gludopa.  (+info)

In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. (8/274)

The aim of this study was to test the hypothesis that in vivo administration of parathyroid hormone (PTH) provokes diuresis/natriuresis through redistribution of proximal tubule apical sodium cotransporters (NHE3 and NaPi2) to internal stores and inhibition of basolateral Na-K-ATPase activity and to determine whether the same cellular signals drive the changes in apical and basolateral transporters. PTH-(1-34) (20 U), which couples to adenylate cyclase (AC), phospholipase C (PLC), and phospholipase A2 (PLA2), or [Nle8,18,Tyr34]PTH-(3-34) (10 U), which couples to PLC and PLA2 but not AC, were given to anesthetized rats as an intravenous bolus followed by low-dose infusion (1 U. kg-1. min-1 for 1 h). Renal cortex membranes were fractionated on sorbitol density gradients. PTH-(1-34) increased urinary cAMP excretion 3-fold, urine output (V) 2.0 +/- 0.1-fold, and lithium clearance (CLi) 2.8 +/- 0.3-fold. With this diuresis/natriuresis, 25% of NHE3 and 18% of NaPi2 immunoreactivity redistributed from apical membranes to higher density fractions containing intracellular membrane markers, and basolateral Na-K-ATPase activity decreased 25%. [Nle8,18,Tyr34]PTH-(3-34) failed to increase V or CLi or to provoke redistribution of NHE3 or NaPi2, but it did inhibit Na-K-ATPase activity 25%. We conclude that in vivo PTH stimulates natriuresis/diuresis associated with internalization of apical NHE3 and NaPi2 and inhibition of Na-K-ATPase activity, that cAMP-protein kinase A stimulation is necessary for the natriuresis/diuresis and NHE3 and NaPi2 internalization, and that Na-K-ATPase inhibition is not secondary to depressed apical Na+ transport.  (+info)

Sodium-phosphate cotransporter proteins are membrane transport proteins that facilitate the active transport of sodium and inorganic phosphate ions across biological membranes. These proteins play a crucial role in maintaining phosphate homeostasis within the body by regulating the absorption and excretion of phosphate in the kidneys and intestines. They exist in two major types, type I (NaPi-I) and type II (NaPi-II), each having multiple subtypes with distinct tissue distributions and regulatory mechanisms.

Type I sodium-phosphate cotransporters are primarily expressed in the kidney's proximal tubules and play a significant role in reabsorbing phosphate from the primary urine back into the bloodstream. Type II sodium-phosphate cotransporters, on the other hand, are found in both the kidneys and intestines. In the kidneys, they contribute to phosphate reabsorption, while in the intestines, they facilitate phosphate absorption from food.

These proteins function by coupling the passive downhill movement of sodium ions (driven by the electrochemical gradient) with the active uphill transport of phosphate ions against their concentration gradient. This coupled transport process enables cells to maintain intracellular phosphate concentrations within a narrow range, despite fluctuations in dietary intake and renal function.

Dysregulation of sodium-phosphate cotransporter proteins has been implicated in various pathological conditions, such as chronic kidney disease (CKD), tumoral calcinosis, and certain genetic disorders affecting phosphate homeostasis.

Sodium-phosphate cotransporter proteins, type II (NPTII), are a group of membrane transport proteins that facilitate the active transport of inorganic phosphate (Pi) and sodium ions (Na+) across the cell membrane. They play a crucial role in maintaining intracellular phosphate homeostasis and regulating various physiological processes, including energy metabolism, signal transduction, and bone mineralization.

The type II sodium-phosphate cotransporters are further divided into three subtypes: NPT2a, NPT2b, and NPT2c. These subtypes differ in their tissue distribution, substrate affinity, and regulatory mechanisms. NPT2a is primarily expressed in the kidney proximal tubules and plays a major role in reabsorbing phosphate from the glomerular filtrate. NPT2b is predominantly found in the small intestine and contributes to phosphate absorption from the diet. NPT2c is widely distributed, with significant expression in the kidney, brain, and testis, although its specific functions are not as well understood as those of NPT2a and NPT2b.

Dysregulation of sodium-phosphate cotransporter proteins, type II, has been implicated in several pathological conditions, such as renal phosphate wasting disorders, tumoral calcinosis, and certain forms of hyperparathyroidism.

Sodium-phosphate cotransporter proteins, type IIa (NaPi-IIa), are a subtype of membrane transport proteins that facilitate the active transport of sodium and phosphate ions across the cell membrane. They play a crucial role in maintaining phosphate homeostasis within the body by regulating the reabsorption of phosphate in the kidney's proximal tubules.

NaPi-IIa proteins are located on the brush border membrane of the proximal tubule cells and function to couple the movement of sodium ions down its electrochemical gradient into the cell with the influx of phosphate ions against its concentration gradient, from the lumen into the cell. This process is driven by the sodium-potassium ATPase pump, which maintains a low intracellular sodium concentration and a negative membrane potential.

NaPi-IIa proteins are encoded by the SLC34A1 gene in humans and are subject to regulation by various hormonal and physiological factors, such as parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and dietary phosphate intake. Dysregulation of NaPi-IIa function has been implicated in several kidney diseases and disorders of phosphate homeostasis, such as hyperphosphatemia and hypophosphatemic rickets.

Sodium-phosphate cotransporter proteins, type I (NaPi-I), are a group of membrane transport proteins that facilitate the active transport of sodium and phosphate ions across the cell membrane. These proteins play a crucial role in regulating phosphate homeostasis in the body by reabsorbing phosphate from the glomerular filtrate in the kidney back into the bloodstream.

The type I sodium-phosphate cotransporters are composed of two subtypes, NaPi-IA and NaPi-IB, which share a similar structure and function. They consist of 13 transmembrane domains, with both the N- and C-termini located in the cytoplasm. These proteins are primarily expressed in the brush border membrane of the proximal tubule cells in the kidney.

NaPi-I proteins function as sodium-phosphate symporters, meaning they transport both sodium and phosphate ions in the same direction. The energy required for this active transport process comes from the electrochemical gradient of sodium ions across the cell membrane, which is maintained by the activity of the Na+/K+-ATPase pump.

Regulation of these proteins is critical for maintaining phosphate balance in the body. In response to changes in dietary phosphate intake or hormonal signals, such as parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), the expression and activity of NaPi-I proteins can be modulated to adjust phosphate reabsorption in the kidney.

In summary, sodium-phosphate cotransporter proteins, type I, are essential membrane transport proteins that regulate phosphate homeostasis by facilitating the active reabsorption of phosphate from the glomerular filtrate in the kidney. Their expression and activity are tightly regulated to maintain proper phosphate balance in the body.

Sodium-phosphate cotransporter proteins, type IIc (NPTIIc), are a subtype of sodium-dependent phosphate transporters that play a crucial role in the regulation of phosphate homeostasis within the body. They are located primarily in the kidney's proximal tubule cells and intestinal epithelial cells.

NPTIIc proteins facilitate the active transport of inorganic phosphate (Pi) ions across the cell membrane, in conjunction with sodium ions (Na+). This symport mechanism allows for the movement of Pi against its concentration gradient, from areas of low concentration to high concentration. The energy required for this process is derived from the electrochemical gradient of sodium ions.

These transporters are essential for maintaining normal phosphate levels in the body, as they help reabsorb a significant portion of filtered phosphate in the kidneys and absorb dietary phosphate in the intestines. Dysregulation of NPTIIc proteins can lead to various disorders related to phosphate homeostasis, such as hypophosphatemia (low serum phosphate levels) or hyperphosphatemia (high serum phosphate levels), which can have detrimental effects on bone health, mineral metabolism, and overall body function.

A symporter is a type of transmembrane protein that functions to transport two or more molecules or ions across a biological membrane in the same direction, simultaneously. This process is called co-transport and it is driven by the concentration gradient of one of the substrates, which is usually an ion such as sodium (Na+) or proton (H+).

Symporters are classified based on the type of energy that drives the transport process. Primary active transporters, such as symporters, use the energy from ATP hydrolysis or from the electrochemical gradient of ions to move substrates against their concentration gradient. In contrast, secondary active transporters use the energy stored in an existing electrochemical gradient of one substrate to drive the transport of another substrate against its own concentration gradient.

Symporters play important roles in various physiological processes, including nutrient uptake, neurotransmitter reuptake, and ion homeostasis. For example, the sodium-glucose transporter (SGLT) is a symporter that co-transports glucose and sodium ions across the intestinal epithelium and the renal proximal tubule, contributing to glucose absorption and regulation of blood glucose levels. Similarly, the dopamine transporter (DAT) is a symporter that co-transports dopamine and sodium ions back into presynaptic neurons, terminating the action of dopamine in the synapse.

Hypophosphatemia is a medical condition characterized by abnormally low levels of phosphate (phosphorus) in the blood, specifically below 2.5 mg/dL. Phosphate is an essential electrolyte that plays a crucial role in various bodily functions such as energy production, bone formation, and maintaining acid-base balance.

Hypophosphatemia can result from several factors, including malnutrition, vitamin D deficiency, alcoholism, hormonal imbalances, and certain medications. Symptoms of hypophosphatemia may include muscle weakness, fatigue, bone pain, confusion, and respiratory failure in severe cases. Treatment typically involves correcting the underlying cause and administering phosphate supplements to restore normal levels.

Sodium-phosphate cotransporter proteins, type IIb (NaPi-IIb), are membrane transport proteins found in the kidney's brush border membrane of proximal tubule cells. They play a crucial role in reabsorbing inorganic phosphate from the primary urine back into the bloodstream. These cotransporters facilitate the active transport of phosphate ions (PO4^3-) coupled with sodium ions (Na+) through the cell membrane, using the energy derived from the electrochemical gradient of sodium ions.

Type IIb sodium-phosphate cotransporters are specifically expressed in the kidney and contribute to maintaining phosphate homeostasis in the body. Disorders in NaPi-IIb function can lead to abnormal phosphate levels, which may be associated with various medical conditions such as hypophosphatemia or hyperphosphatemia.

Sodium-phosphate cotransporter proteins, type III (NPTIII), are a subfamily of sodium-dependent phosphate transporters that play a crucial role in the regulation of phosphate homeostasis within the body. They are located primarily in the proximal tubule cells of the kidney and facilitate the active transport of inorganic phosphate (Pi) from the lumen into the cell, coupled with the movement of sodium ions (Na+) in the same direction.

The type III sodium-phosphate cotransporters consist of two isoforms, NaPi-IIa and NaPi-IIc, which are encoded by the SLC34A1 and SLC34A3 genes, respectively. These proteins have a molecular weight of approximately 80-90 kDa and contain 13 transmembrane domains, with both the N- and C-termini located intracellularly.

NaPi-IIa is responsible for the majority of sodium-dependent phosphate reabsorption in the kidney, while NaPi-IIc plays a modulatory role under conditions of high dietary phosphate intake or during development. Dysregulation of these cotransporters has been implicated in various pathological conditions, such as chronic kidney disease (CKD), tumoral calcinosis, and certain forms of hypophosphatemic rickets.

In summary, sodium-phosphate cotransporter proteins, type III, are essential for maintaining phosphate balance by mediating the active reabsorption of inorganic phosphate from the kidney tubular lumen into the bloodstream.

Phosphates, in a medical context, refer to the salts or esters of phosphoric acid. Phosphates play crucial roles in various biological processes within the human body. They are essential components of bones and teeth, where they combine with calcium to form hydroxyapatite crystals. Phosphates also participate in energy transfer reactions as phosphate groups attached to adenosine diphosphate (ADP) and adenosine triphosphate (ATP). Additionally, they contribute to buffer systems that help maintain normal pH levels in the body.

Abnormal levels of phosphates in the blood can indicate certain medical conditions. High phosphate levels (hyperphosphatemia) may be associated with kidney dysfunction, hyperparathyroidism, or excessive intake of phosphate-containing products. Low phosphate levels (hypophosphatemia) might result from malnutrition, vitamin D deficiency, or certain diseases affecting the small intestine or kidneys. Both hypophosphatemia and hyperphosphatemia can have significant impacts on various organ systems and may require medical intervention.

Sodium-Potassium-Chloride Symporters are membrane transport proteins that facilitate the active transport of sodium, potassium, and chloride ions across the cell membrane. These symporters use the energy derived from the concentration gradient of sodium ions to co-transport potassium and chloride ions into or out of the cell. This process helps maintain electrolyte balance, regulate cell volume, and facilitate various physiological functions such as nerve impulse transmission and kidney function. An example of a Sodium-Potassium-Chloride Symporter is the NKCC1 (Na-K-2Cl cotransporter).

Cathartics are a type of medication that stimulates bowel movements and evacuates the intestinal tract. They are often used to treat constipation or to prepare the bowel for certain medical procedures, such as colonoscopies. Common cathartic medications include laxatives, enemas, and suppositories.

Cathartics work by increasing the muscle contractions of the intestines, which helps to move stool through the digestive tract more quickly. They may also increase the amount of water in the stool, making it softer and easier to pass. Some cathartics, such as bulk-forming laxatives, work by absorbing water and swelling in the intestines, which helps to bulk up the stool and stimulate a bowel movement.

While cathartics can be effective at relieving constipation, they should be used with caution. Overuse of cathartics can lead to dependence on them for bowel movements, as well as electrolyte imbalances and other complications. It is important to follow the instructions carefully when using cathartic medications and to speak with a healthcare provider if constipation persists or worsens.

Sodium is an essential mineral and electrolyte that is necessary for human health. In a medical context, sodium is often discussed in terms of its concentration in the blood, as measured by serum sodium levels. The normal range for serum sodium is typically between 135 and 145 milliequivalents per liter (mEq/L).

Sodium plays a number of important roles in the body, including:

* Regulating fluid balance: Sodium helps to regulate the amount of water in and around your cells, which is important for maintaining normal blood pressure and preventing dehydration.
* Facilitating nerve impulse transmission: Sodium is involved in the generation and transmission of electrical signals in the nervous system, which is necessary for proper muscle function and coordination.
* Assisting with muscle contraction: Sodium helps to regulate muscle contractions by interacting with other minerals such as calcium and potassium.

Low sodium levels (hyponatremia) can cause symptoms such as confusion, seizures, and coma, while high sodium levels (hypernatremia) can lead to symptoms such as weakness, muscle cramps, and seizures. Both conditions require medical treatment to correct.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

I'm sorry for any confusion, but "opossums" are not a medical term or a medical condition. Opossums are actually marsupials (pouched mammals) that are native to the Americas. They are often known for their "playing dead" behavior as a defense mechanism when threatened. If you have any questions about medical terminology or health-related topics, I'd be happy to help with those!

Microvilli are small, finger-like projections that line the apical surface (the side facing the lumen) of many types of cells, including epithelial and absorptive cells. They serve to increase the surface area of the cell membrane, which in turn enhances the cell's ability to absorb nutrients, transport ions, and secrete molecules.

Microvilli are typically found in high density and are arranged in a brush-like border called the "brush border." They contain a core of actin filaments that provide structural support and allow for their movement and flexibility. The membrane surrounding microvilli contains various transporters, channels, and enzymes that facilitate specific functions related to absorption and secretion.

In summary, microvilli are specialized structures on the surface of cells that enhance their ability to interact with their environment by increasing the surface area for transport and secretory processes.

Familial Hypophosphatemic Rickets (FHR) is a genetic disorder characterized by impaired reabsorption of phosphate in the kidneys, leading to low levels of phosphate in the blood (hypophosphatemia). This condition results in defective mineralization of bones and teeth, causing rickets in children and osteomalacia in adults.

FHR is typically caused by mutations in the PHEX gene, which encodes a protein that helps regulate phosphate levels in the body. In FHR, the mutation leads to an overproduction of a hormone called fibroblast growth factor 23 (FGF23), which increases phosphate excretion in the urine and decreases the activation of vitamin D, further contributing to hypophosphatemia.

Symptoms of FHR may include bowing of the legs, bone pain, muscle weakness, short stature, dental abnormalities, and skeletal deformities. Treatment typically involves oral phosphate supplements and active forms of vitamin D to correct the hypophosphatemia and improve bone mineralization. Regular monitoring of blood phosphate levels, kidney function, and bone health is essential for effective management of this condition.

The proximal kidney tubule is the initial portion of the renal tubule in the nephron of the kidney. It is located in the renal cortex and is called "proximal" because it is closer to the glomerulus, compared to the distal tubule. The proximal tubule plays a crucial role in the reabsorption of water, electrolytes, and nutrients from the filtrate that has been formed by the glomerulus. It also helps in the secretion of waste products and other substances into the urine.

The proximal tubule is divided into two segments: the pars convoluta and the pars recta. The pars convoluta is the curved portion that receives filtrate from the Bowman's capsule, while the pars recta is the straight portion that extends deeper into the renal cortex.

The proximal tubule is lined with a simple cuboidal epithelium, and its cells are characterized by numerous mitochondria, which provide energy for active transport processes. The apical surface of the proximal tubular cells has numerous microvilli, forming a brush border that increases the surface area for reabsorption.

In summary, the proximal kidney tubule is a critical site for the reabsorption of water, electrolytes, and nutrients from the glomerular filtrate, contributing to the maintenance of fluid and electrolyte balance in the body.

Bisacodyl is a stimulant laxative that is used to treat constipation and to clean out the intestines before a colonoscopy or other medical procedures. It works by increasing the muscle contractions in the intestines, which helps to move stool through the bowels and promotes bowel movements. Bisacodyl is available as a tablet or suppository, and it is typically taken at night to produce a bowel movement the next morning.

Bisacodyl is a prescription medication, and it should be used under the guidance of a healthcare professional. It is important to follow the instructions for use carefully, as improper use can increase the risk of side effects such as dehydration, electrolyte imbalances, and dependence on laxatives.

Some common side effects of bisacodyl include abdominal cramping, diarrhea, and nausea. These side effects are usually mild and go away on their own. However, if they are severe or persist, it is important to talk to a healthcare professional. In rare cases, bisacodyl can cause more serious side effects such as allergic reactions, heart problems, and intestinal inflammation. If you experience any of these side effects, seek medical attention immediately.

It is important to note that bisacodyl is not recommended for long-term use, as it can lead to dependence on laxatives and other health problems. It should only be used as directed by a healthcare professional and for the shortest duration necessary to treat constipation or prepare for a medical procedure.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

A Sodium-Hydrogen Antiporter (NHA) is a type of membrane transport protein that exchanges sodium ions (Na+) and protons (H+) across a biological membrane. It is also known as a Na+/H+ antiporter or exchanger. This exchange mechanism plays a crucial role in regulating pH, cell volume, and intracellular sodium concentration within various cells and organelles, including the kidney, brain, heart, and mitochondria.

In general, NHA transporters utilize the energy generated by the electrochemical gradient of sodium ions across a membrane to drive the uphill transport of protons from inside to outside the cell or organelle. This process helps maintain an optimal intracellular pH and volume, which is essential for proper cellular function and homeostasis.

There are several isoforms of Sodium-Hydrogen Antiporters found in different tissues and organelles, each with distinct physiological roles and regulatory mechanisms. Dysfunction or alterations in NHA activity have been implicated in various pathophysiological conditions, such as hypertension, heart failure, neurological disorders, and cancer.

A colonoscopy is a medical procedure used to examine the large intestine, also known as the colon and rectum. It is performed using a flexible tube with a tiny camera on the end, called a colonoscope, which is inserted into the rectum and gently guided through the entire length of the colon.

The procedure allows doctors to visually inspect the lining of the colon for any abnormalities such as polyps, ulcers, inflammation, or cancer. If any polyps are found during the procedure, they can be removed immediately using special tools passed through the colonoscope. Colonoscopy is an important tool in the prevention and early detection of colorectal cancer, which is one of the leading causes of cancer-related deaths worldwide.

Patients are usually given a sedative to help them relax during the procedure, which is typically performed on an outpatient basis in a hospital or clinic setting. The entire procedure usually takes about 30-60 minutes to complete, although patients should plan to spend several hours at the medical facility for preparation and recovery.

Sodium-bicarbonate symporters, also known as sodium bicarbonate co-transporters, are membrane transport proteins that facilitate the movement of both sodium ions (Na+) and bicarbonate ions (HCO3-) across the cell membrane in the same direction. These transporters play a crucial role in maintaining acid-base balance in the body by regulating the concentration of bicarbonate ions, which is an important buffer in the blood and other bodily fluids.

The term "symporter" refers to the fact that these proteins transport two or more different molecules or ions in the same direction across a membrane. In this case, sodium-bicarbonate symporters co-transport one sodium ion and one bicarbonate ion together, usually using a concentration gradient of sodium to drive the uptake of bicarbonate.

These transporters are widely expressed in various tissues, including the kidneys, where they help reabsorb bicarbonate ions from the urine back into the bloodstream, and the gastrointestinal tract, where they contribute to the absorption of sodium and bicarbonate from food and drink. Dysfunction of sodium-bicarbonate symporters has been implicated in several diseases, including renal tubular acidosis and hypertension.

Sodium chloride symporters are membrane transport proteins that actively co-transport sodium and chloride ions into a cell. They are also known as sodium-chloride cotransporters or NCCs. These transporters play a crucial role in regulating the electrolyte balance and water homeostasis in various tissues, particularly in the kidney's distal convoluted tubule.

The primary function of sodium chloride symporters is to reabsorb sodium and chloride ions from the filtrate in the nephron back into the bloodstream. By doing so, they help maintain the body's sodium concentration and control water balance through osmosis.

Mutations in the gene encoding for the NCC can lead to various kidney disorders, such as Gitelman syndrome or Bartter syndrome type III, which are characterized by electrolyte imbalances, low blood pressure, and metabolic alkalosis.

Solute Carrier Family 12, Member 2 (SLC12A2) is a gene that encodes for a protein called the potassium-chloride cotransporter type 2 (KCC2). This protein is a member of the solute carrier family, which are membrane transport proteins that move various molecules across cell membranes. KCC2 is specifically responsible for the active transport of chloride and potassium ions out of neurons in the brain and spinal cord.

KCC2 plays a crucial role in maintaining the proper balance of ions within neurons, which is essential for normal electrical signaling and communication between nerve cells. Mutations in the SLC12A2 gene have been associated with several neurological disorders, including epilepsy, infantile spasms, and intellectual disability.

Sodium-Glucose Transporter 1 (SGLT1) is a protein found in the membrane of intestinal and kidney cells. It is responsible for the active transport of glucose and sodium ions from the lumen into the epithelial cells. In the intestine, SGLT1 plays a crucial role in glucose absorption after meals, while in the kidneys, it helps reabsorb glucose back into the bloodstream to prevent wasting through urine. The transport process is driven by the sodium gradient created by Na+/K+ ATPase, which actively pumps sodium ions out of the cell. SGLT1 inhibitors are used in the treatment of type 2 diabetes to reduce glucose reabsorption and enhance urinary glucose excretion, leading to better glycemic control.

Therapeutic irrigation, also known as lavage, is a medical procedure that involves the introduction of fluids or other agents into a body cavity or natural passageway for therapeutic purposes. This technique is used to cleanse, flush out, or introduce medication into various parts of the body, such as the bladder, lungs, stomach, or colon.

The fluid used in therapeutic irrigation can be sterile saline solution, distilled water, or a medicated solution, depending on the specific purpose of the procedure. The flow and pressure of the fluid are carefully controlled to ensure that it reaches the desired area without causing damage to surrounding tissues.

Therapeutic irrigation is used to treat a variety of medical conditions, including infections, inflammation, obstructions, and toxic exposures. It can also be used as a diagnostic tool to help identify abnormalities or lesions within body cavities.

Overall, therapeutic irrigation is a valuable technique in modern medicine that allows healthcare providers to deliver targeted treatment directly to specific areas of the body, improving patient outcomes and quality of life.

Senna extract is a herbal preparation made from the leaves and fruit of the senna plant (Cassia senna or Cassia angustifolia), which belongs to the Fabaceae family. The active components in senna extract are anthraquinone glycosides, primarily sennosides A and B, that have laxative properties.

The medical definition of Senna extract is:
A standardized herbal extract derived from the leaves or fruit of the senna plant, containing a specific amount of sennosides (usually expressed as a percentage). It is used medically as a stimulant laxative to treat constipation and prepare the bowel for diagnostic procedures like colonoscopies. The laxative effect of senna extract is due to increased peristalsis and inhibition of water and electrolyte absorption in the large intestine, which results in softer stools and easier evacuation.

It's important to note that long-term use or misuse of senna extract can lead to dependence, electrolyte imbalances, and potential damage to the colon. Therefore, medical supervision is recommended when using senna extract as a laxative.

Laxatives are substances or medications that are used to promote bowel movements or loosen the stools, thereby helping in the treatment of constipation. They work by increasing the amount of water in the stool or stimulating the muscles in the intestines to contract and push the stool through. Laxatives can be categorized into several types based on their mechanism of action, including bulk-forming laxatives, lubricant laxatives, osmotic laxatives, saline laxatives, stimulant laxatives, and stool softeners. It is important to use laxatives only as directed by a healthcare professional, as overuse or misuse can lead to serious health complications.

Bumetanide is a loop diuretic medication that is primarily used to treat fluid buildup and swelling caused by various medical conditions, such as heart failure, liver cirrhosis, and kidney disease. It works by increasing the excretion of salt and water from the body through urination.

The increased urine output helps reduce the amount of fluid in the body, which can help alleviate symptoms such as shortness of breath, weight gain, and swelling in the legs, ankles, and feet. Bumetanide is a potent diuretic and should be used under the close supervision of a healthcare provider to monitor its effects on the body's electrolyte balance and fluid levels.

Like other loop diuretics, bumetanide can cause side effects such as dehydration, electrolyte imbalances, hearing loss, and kidney damage if used inappropriately or in excessive doses. It is important to follow the prescribed dosage regimen and inform your healthcare provider of any changes in your health status while taking this medication.

Solute Carrier Family 12, Member 1 (SLC12A1) is a protein that functions as a sodium-potassium-chloride cotransporter (NKCC1). It is responsible for the transport of sodium, potassium, and chloride ions across the membrane of cells. This transporter plays a crucial role in regulating the volume and composition of fluids in various tissues, including the inner ear and brain. Dysfunction of this protein has been implicated in several medical conditions, such as hearing loss, balance disorders, and neurological disorders.

Sodium-potassium-chloride symporters, also known as sodium-potassium-chloride cotransporters or NKCCs, are a type of membrane transport protein that facilitates the movement of ions across the cell membrane. Specifically, they mediate the simultaneous transport of sodium (Na+), potassium (K+), and chloride (Cl-) ions into cells.

Sodium-potassium-chloride symporter inhibitors are pharmacological agents that block the activity of these transporters, thereby preventing the uptake of these ions into cells. These drugs have been used in various clinical settings to treat or manage conditions such as hypertension, edema, and certain types of epilepsy.

Examples of sodium-potassium-chloride symporter inhibitors include loop diuretics such as furosemide, bumetanide, and torasemide, which target the NKCC2 transporter in the thick ascending limb of the loop of Henle in the kidney. By blocking this transporter, these drugs increase sodium and water excretion, reducing blood volume and lowering blood pressure.

It's worth noting that while "sodium-potassium-chloride symporter inhibitors" is a valid term, it may be less commonly used than more specific terms such as "loop diuretics."

"Pharmaceutical solutions" is a term that refers to medications or drugs that are formulated in a liquid state, as opposed to solid forms like tablets or capsules. These solutions are typically created by dissolving the active pharmaceutical ingredient (API) in a solvent, such as water or ethanol, along with other excipients that help stabilize and preserve the solution.

Pharmaceutical solutions can be administered to patients through various routes, including oral, intravenous, subcutaneous, or intramuscular injection, depending on the desired site of action and the specific properties of the drug. Some examples of pharmaceutical solutions include antibiotic infusions, pain medications, and electrolyte replacement drinks.

It's important to note that the term "pharmaceutical solutions" can also refer more broadly to the process of developing and manufacturing drugs, as well as to the industry as a whole. However, in a medical context, it most commonly refers to liquid medications.

Antifoaming agents are substances that prevent or reduce the formation of foam in liquids. They are often used in industrial processes, such as manufacturing and food production, to minimize the negative effects of foam on equipment performance, product quality, and safety. In a medical context, antifoaming agents may be used in certain medications, intravenous (IV) fluids, or enteral feedings to prevent or treat foaming that can interfere with proper administration or absorption of the treatment.

These agents work by reducing surface tension, promoting bubble rupture, or absorbing excess gases. Common antifoaming agents include silicone-based compounds, such as dimethicone and simethicone, as well as other substances like polyoxyethylene sorbitan monostearate (Tween) and alcohols.

In some cases, antifoaming agents may be used during medical procedures to prevent or treat the accumulation of foam in body cavities, such as the stomach or lungs. For instance, simethicone is sometimes administered to newborns with meconium ileus (a bowel obstruction caused by thickened meconium) to help reduce the formation of gas and facilitate the passage of meconium. Similarly, antifoaming agents may be used in mechanical ventilation to prevent or treat pulmonary air leaks and improve oxygenation.

While antifoaming agents are generally considered safe when used as directed, they can have side effects, particularly if overused or misused. Potential adverse reactions include gastrointestinal symptoms like diarrhea, nausea, or bloating, as well as allergic reactions in sensitive individuals. It is essential to follow the recommended dosage and administration guidelines provided by a healthcare professional when using antifoaming agents for medical purposes.

An enema is a medical procedure in which liquid is introduced into the lower part of the large intestine, specifically the sigmoid colon or rectum, through the anus using a special device called an enema kit. The liquid used can be plain water, saline solution, or a medicated solution, and it is typically retained for a short period of time before being expelled.

The purpose of an enema may vary, but it is often used to relieve constipation, prepare the bowel for medical procedures such as colonoscopy, or administer medications or nutrients that cannot be taken by mouth. Enemas can also be used for therapeutic purposes, such as to stimulate the immune system or promote relaxation.

It is important to follow proper instructions when administering an enema to avoid injury or discomfort. Possible side effects of enemas may include cramping, bloating, nausea, or electrolyte imbalances. If you have any health concerns or conditions that may be affected by an enema, it is recommended to consult with a healthcare professional before using one.

Solute Carrier Family 12, Member 3 (SLC12A3) is a protein that belongs to the solute carrier family, which are membrane transport proteins involved in the movement of various substances across cell membranes. Specifically, SLC12A3 is a member of the electroneutral cation-chloride cotransporter (CCC) family and encodes for the protein known as downregulated in adenoma maturity alpha (DRA).

The DRA protein functions as an apical membrane transporter that mediates the coupled movement of sodium, chloride, and bicarbonate ions across epithelial cells. It is primarily expressed in the colon, where it plays a critical role in maintaining electrolyte homeostasis by facilitating the absorption of sodium and chloride ions from the intestinal lumen into the bloodstream.

Mutations in the SLC12A3 gene have been associated with several human diseases, including congenital chloride diarrhea (CLD), a rare autosomal recessive disorder characterized by chronic watery diarrhea due to excessive loss of sodium and chloride ions.

Hydrogen-ion concentration, also known as pH, is a measure of the acidity or basicity of a solution. It is defined as the negative logarithm (to the base 10) of the hydrogen ion activity in a solution. The standard unit of measurement is the pH unit. A pH of 7 is neutral, less than 7 is acidic, and greater than 7 is basic.

In medical terms, hydrogen-ion concentration is important for maintaining homeostasis within the body. For example, in the stomach, a high hydrogen-ion concentration (low pH) is necessary for the digestion of food. However, in other parts of the body such as blood, a high hydrogen-ion concentration can be harmful and lead to acidosis. Conversely, a low hydrogen-ion concentration (high pH) in the blood can lead to alkalosis. Both acidosis and alkalosis can have serious consequences on various organ systems if not corrected.

Familial Hypophosphatemia is a genetic disorder characterized by low levels of phosphate in the blood (hypophosphatemia) due to impaired absorption of phosphates in the gut. This condition results from mutations in the SLC34A3 gene, which provides instructions for making a protein called NaPi-IIc, responsible for reabsorbing phosphates from the filtrate in the kidney tubules back into the bloodstream.

In familial hypophosphatemia, the impaired function of NaPi-IIc leads to excessive loss of phosphate through urine, resulting in hypophosphatemia. This condition can cause rickets (a softening and weakening of bones) in children and osteomalacia (softening of bones) in adults. Symptoms may include bowed legs, bone pain, muscle weakness, and short stature.

Familial Hypophosphatemia is inherited as an autosomal recessive trait, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

A buffer in the context of physiology and medicine refers to a substance or system that helps to maintain stable or neutral conditions, particularly in relation to pH levels, within the body or biological fluids.

Buffers are weak acids or bases that can react with strong acids or bases to minimize changes in the pH level. They do this by taking up excess hydrogen ions (H+) when acidity increases or releasing hydrogen ions when alkalinity increases, thereby maintaining a relatively constant pH.

In the human body, some of the key buffer systems include:

1. Bicarbonate buffer system: This is the major buffer in blood and extracellular fluids. It consists of bicarbonate ions (HCO3-) and carbonic acid (H2CO3). When there is an increase in acidity, the bicarbonate ion accepts a hydrogen ion to form carbonic acid, which then dissociates into water and carbon dioxide. The carbon dioxide can be exhaled, helping to remove excess acid from the body.
2. Phosphate buffer system: This is primarily found within cells. It consists of dihydrogen phosphate (H2PO4-) and monohydrogen phosphate (HPO42-) ions. When there is an increase in alkalinity, the dihydrogen phosphate ion donates a hydrogen ion to form monohydrogen phosphate, helping to neutralize the excess base.
3. Protein buffer system: Proteins, particularly histidine-rich proteins, can also act as buffers due to the presence of ionizable groups on their surfaces. These groups can bind or release hydrogen ions in response to changes in pH, thus maintaining a stable environment within cells and organelles.

Maintaining appropriate pH levels is crucial for various biological processes, including enzyme function, cell membrane stability, and overall homeostasis. Buffers play a vital role in preserving these balanced conditions despite internal or external challenges that might disrupt them.

Betamethasone is a type of corticosteroid medication that is used to treat various medical conditions. It works by reducing inflammation and suppressing the activity of the immune system. Betamethasone is available in several forms, including creams, ointments, lotions, gels, solutions, tablets, and injectable preparations.

The medical definition of betamethasone is:

A synthetic corticosteroid with anti-inflammatory, immunosuppressive, and vasoconstrictive properties. It is used to treat a variety of conditions such as skin disorders, allergies, asthma, arthritis, and autoimmune diseases. Betamethasone is available in various formulations including topical (creams, ointments, lotions, gels), oral (tablets), and injectable preparations. It acts by binding to specific receptors in cells, which leads to the inhibition of the production of inflammatory mediators and the suppression of immune responses.

It is important to note that betamethasone should be used under the guidance of a healthcare professional, as it can have significant side effects if not used properly.

Simethicone is an anti-foaming agent that is commonly used in the medical field, particularly for the treatment of gastric symptoms such as bloating and discomfort caused by excessive gas in the gastrointestinal tract. It works by reducing the surface tension of gas bubbles in the stomach and intestines, allowing them to combine and be expelled more easily from the body.

Simethicone is not absorbed into the bloodstream and has minimal systemic absorption, making it a safe and well-tolerated medication for most individuals. It can be found in various forms, including tablets, chewable tablets, capsules, and liquids, and is often combined with other medications to provide symptomatic relief of gastric discomfort.

It's important to note that simethicone should only be used as directed by a healthcare professional, and individuals should always consult their doctor or pharmacist before taking any new medication.

Sodium channels are specialized protein structures that are embedded in the membranes of excitable cells, such as nerve and muscle cells. They play a crucial role in the generation and transmission of electrical signals in these cells. Sodium channels are responsible for the rapid influx of sodium ions into the cell during the initial phase of an action potential, which is the electrical signal that travels along the membrane of a neuron or muscle fiber. This sudden influx of sodium ions causes the membrane potential to rapidly reverse, leading to the depolarization of the cell. After the action potential, the sodium channels close and become inactivated, preventing further entry of sodium ions and helping to restore the resting membrane potential.

Sodium channels are composed of a large alpha subunit and one or two smaller beta subunits. The alpha subunit forms the ion-conducting pore, while the beta subunits play a role in modulating the function and stability of the channel. Mutations in sodium channel genes have been associated with various inherited diseases, including certain forms of epilepsy, cardiac arrhythmias, and muscle disorders.

I'm sorry for any confusion, but "picolines" is not a term commonly used in medical definitions. It is a term that refers to a group of chemical compounds known as methylated benzenes or xylenols. They have some industrial uses, but they are not typically relevant in the context of medical definitions or healthcare. If you have any questions related to medical terminology or health concerns, I'd be happy to try and help with those instead!

Polyethylene glycols (PEGs) are a family of synthetic, water-soluble polymers with a wide range of molecular weights. They are commonly used in the medical field as excipients in pharmaceutical formulations due to their ability to improve drug solubility, stability, and bioavailability. PEGs can also be used as laxatives to treat constipation or as bowel cleansing agents prior to colonoscopy examinations. Additionally, some PEG-conjugated drugs have been developed for use in targeted cancer therapies.

In a medical context, PEGs are often referred to by their average molecular weight, such as PEG 300, PEG 400, PEG 1500, and so on. Higher molecular weight PEGs tend to be more viscous and have longer-lasting effects in the body.

It's worth noting that while PEGs are generally considered safe for use in medical applications, some people may experience allergic reactions or hypersensitivity to these compounds. Prolonged exposure to high molecular weight PEGs has also been linked to potential adverse effects, such as decreased fertility and developmental toxicity in animal studies. However, more research is needed to fully understand the long-term safety of PEGs in humans.

Nephrocalcinosis is a medical condition characterized by the deposition of calcium salts in the renal parenchyma, specifically within the tubular epithelial cells and interstitium of the kidneys. This process can lead to chronic inflammation, tissue damage, and ultimately impaired renal function if left untreated.

The condition is often associated with metabolic disorders such as hyperparathyroidism, distal renal tubular acidosis, or hyperoxaluria; medications like loop diuretics, corticosteroids, or calcineurin inhibitors; and chronic kidney diseases. The diagnosis of nephrocalcinosis is typically made through imaging studies such as ultrasound, CT scan, or X-ray. Treatment usually involves addressing the underlying cause, modifying dietary habits, and administering medications to control calcium levels in the body.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Calcium phosphates are a group of minerals that are important components of bones and teeth. They are also found in some foods and are used in dietary supplements and medical applications. Chemically, calcium phosphates are salts of calcium and phosphoric acid, and they exist in various forms, including hydroxyapatite, which is the primary mineral component of bone tissue. Other forms of calcium phosphates include monocalcium phosphate, dicalcium phosphate, and tricalcium phosphate, which are used as food additives and dietary supplements. Calcium phosphates are important for maintaining strong bones and teeth, and they also play a role in various physiological processes, such as nerve impulse transmission and muscle contraction.

Chlorides are simple inorganic ions consisting of a single chlorine atom bonded to a single charged hydrogen ion (H+). Chloride is the most abundant anion (negatively charged ion) in the extracellular fluid in the human body. The normal range for chloride concentration in the blood is typically between 96-106 milliequivalents per liter (mEq/L).

Chlorides play a crucial role in maintaining electrical neutrality, acid-base balance, and osmotic pressure in the body. They are also essential for various physiological processes such as nerve impulse transmission, maintenance of membrane potentials, and digestion (as hydrochloric acid in the stomach).

Chloride levels can be affected by several factors, including diet, hydration status, kidney function, and certain medical conditions. Increased or decreased chloride levels can indicate various disorders, such as dehydration, kidney disease, Addison's disease, or diabetes insipidus. Therefore, monitoring chloride levels is essential for assessing a person's overall health and diagnosing potential medical issues.

Sodium Chloride is defined as the inorganic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. It is commonly known as table salt or halite, and it is used extensively in food seasoning and preservation due to its ability to enhance flavor and inhibit bacterial growth. In medicine, sodium chloride is used as a balanced electrolyte solution for rehydration and as a topical wound irrigant and antiseptic. It is also an essential component of the human body's fluid balance and nerve impulse transmission.

Glucose-6-phosphate (G6P) is a vital intermediate compound in the metabolism of glucose, which is a simple sugar that serves as a primary source of energy for living organisms. G6P plays a critical role in both glycolysis and gluconeogenesis pathways, contributing to the regulation of blood glucose levels and energy production within cells.

In biochemistry, glucose-6-phosphate is defined as:

A hexose sugar phosphate ester formed by the phosphorylation of glucose at the 6th carbon atom by ATP in a reaction catalyzed by the enzyme hexokinase or glucokinase. This reaction is the first step in both glycolysis and glucose storage (glycogen synthesis) processes, ensuring that glucose can be effectively utilized for energy production or stored for later use.

G6P serves as a crucial metabolic branch point, leading to various pathways such as:

1. Glycolysis: In the presence of sufficient ATP and NAD+ levels, G6P is further metabolized through glycolysis to generate pyruvate, which enters the citric acid cycle for additional energy production in the form of ATP, NADH, and FADH2.
2. Gluconeogenesis: During periods of low blood glucose levels, G6P can be synthesized back into glucose through the gluconeogenesis pathway, primarily occurring in the liver and kidneys. This process helps maintain stable blood glucose concentrations and provides energy to cells when dietary intake is insufficient.
3. Pentose phosphate pathway (PPP): A portion of G6P can be shunted into the PPP, an alternative metabolic route that generates NADPH, ribose-5-phosphate for nucleotide synthesis, and erythrose-4-phosphate for aromatic amino acid production. The PPP is essential in maintaining redox balance within cells and supporting biosynthetic processes.

Overall, glucose-6-phosphate plays a critical role as a central metabolic intermediate, connecting various pathways to regulate energy homeostasis, redox balance, and biosynthesis in response to cellular demands and environmental cues.

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme that plays a crucial role in the metabolic pathway of glycolysis. Its primary function is to convert glyceraldehyde-3-phosphate (a triose sugar phosphate) into D-glycerate 1,3-bisphosphate, while also converting nicotinamide adenine dinucleotide (NAD+) into its reduced form NADH. This reaction is essential for the production of energy in the form of adenosine triphosphate (ATP) during cellular respiration. GAPDH has also been implicated in various non-metabolic processes, including DNA replication, repair, and transcription regulation, due to its ability to interact with different proteins and nucleic acids.

Phosphorus is an essential mineral that is required by every cell in the body for normal functioning. It is a key component of several important biomolecules, including adenosine triphosphate (ATP), which is the primary source of energy for cells, and deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which are the genetic materials in cells.

Phosphorus is also a major constituent of bones and teeth, where it combines with calcium to provide strength and structure. In addition, phosphorus plays a critical role in various metabolic processes, including energy production, nerve impulse transmission, and pH regulation.

The medical definition of phosphorus refers to the chemical element with the atomic number 15 and the symbol P. It is a highly reactive non-metal that exists in several forms, including white phosphorus, red phosphorus, and black phosphorus. In the body, phosphorus is primarily found in the form of organic compounds, such as phospholipids, phosphoproteins, and nucleic acids.

Abnormal levels of phosphorus in the body can lead to various health problems. For example, high levels of phosphorus (hyperphosphatemia) can occur in patients with kidney disease or those who consume large amounts of phosphorus-rich foods, and can contribute to the development of calcification of soft tissues and cardiovascular disease. On the other hand, low levels of phosphorus (hypophosphatemia) can occur in patients with malnutrition, vitamin D deficiency, or alcoholism, and can lead to muscle weakness, bone pain, and an increased risk of infection.

Sugar phosphates are organic compounds that play crucial roles in various biological processes, particularly in the field of genetics and molecular biology. They are formed by the attachment of a phosphate group to a sugar molecule, most commonly to the 5-carbon sugar ribose or deoxyribose.

In genetics, sugar phosphates form the backbone of nucleic acids, such as DNA and RNA. In DNA, the sugar phosphate backbone consists of alternating deoxyribose (a sugar) and phosphate groups, linked together by covalent bonds between the 5' carbon atom of one sugar molecule and the 3' carbon atom of another sugar molecule. This forms a long, twisted ladder-like structure known as a double helix.

Similarly, in RNA, the sugar phosphate backbone is formed by ribose (a sugar) and phosphate groups, creating a single-stranded structure that can fold back on itself to form complex shapes. These sugar phosphate backbones provide structural support for the nucleic acids and help to protect the genetic information stored within them.

Sugar phosphates also play important roles in energy metabolism, as they are involved in the formation and breakdown of high-energy compounds such as ATP (adenosine triphosphate) and GTP (guanosine triphosphate). These molecules serve as energy currency for cells, storing and releasing energy as needed to power various cellular processes.

Phlorhizin is not a medical condition or term, but rather a chemical compound. It is a glucoside that can be found in the bark of apple trees and other related plants. Phlorhizin has been studied in the field of medicine for its potential effects on various health conditions. Specifically, it has been shown to inhibit the enzyme called glucose transporter 2 (GLUT2), which is involved in the absorption of glucose in the body. As a result, phlorhizin has been investigated as a potential treatment for diabetes, as it may help regulate blood sugar levels. However, more research is needed to fully understand its effects and safety profile before it can be used as a medical treatment.

Electrolytes are substances that, when dissolved in water, break down into ions that can conduct electricity. In the body, electrolytes are responsible for regulating various important physiological functions, including nerve and muscle function, maintaining proper hydration and acid-base balance, and helping to repair tissue damage.

The major electrolytes found in the human body include sodium, potassium, chloride, bicarbonate, calcium, magnesium, and phosphate. These electrolytes are tightly regulated by various mechanisms, including the kidneys, which help to maintain their proper balance in the body.

When there is an imbalance of electrolytes in the body, it can lead to a range of symptoms and health problems. For example, low levels of sodium (hyponatremia) can cause confusion, seizures, and even coma, while high levels of potassium (hyperkalemia) can lead to heart arrhythmias and muscle weakness.

Electrolytes are also lost through sweat during exercise or illness, so it's important to replace them through a healthy diet or by drinking fluids that contain electrolytes, such as sports drinks or coconut water. In some cases, electrolyte imbalances may require medical treatment, such as intravenous (IV) fluids or medication.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Citric acid is a weak organic acid that is widely found in nature, particularly in citrus fruits such as lemons and oranges. Its chemical formula is C6H8O7, and it exists in a form known as a tribasic acid, which means it can donate three protons in chemical reactions.

In the context of medical definitions, citric acid may be mentioned in relation to various physiological processes, such as its role in the Krebs cycle (also known as the citric acid cycle), which is a key metabolic pathway involved in energy production within cells. Additionally, citric acid may be used in certain medical treatments or therapies, such as in the form of citrate salts to help prevent the formation of kidney stones. It may also be used as a flavoring agent or preservative in various pharmaceutical preparations.

Colonic diseases refer to a group of medical conditions that affect the colon, also known as the large intestine or large bowel. The colon is the final segment of the digestive system, responsible for absorbing water and electrolytes, and storing and eliminating waste products.

Some common colonic diseases include:

1. Inflammatory bowel disease (IBD): This includes conditions such as Crohn's disease and ulcerative colitis, which cause inflammation and irritation in the lining of the digestive tract.
2. Diverticular disease: This occurs when small pouches called diverticula form in the walls of the colon, leading to symptoms such as abdominal pain, bloating, and changes in bowel movements.
3. Colorectal cancer: This is a type of cancer that develops in the colon or rectum, often starting as benign polyps that grow and become malignant over time.
4. Irritable bowel syndrome (IBS): This is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel movements, but without any underlying structural or inflammatory causes.
5. Constipation: This is a common condition characterized by infrequent bowel movements, difficulty passing stools, or both.
6. Infectious colitis: This occurs when the colon becomes infected with bacteria, viruses, or parasites, leading to symptoms such as diarrhea, abdominal cramps, and fever.

Treatment for colonic diseases varies depending on the specific condition and its severity. Treatment options may include medications, lifestyle changes, surgery, or a combination of these approaches.

"Xenopus laevis" is not a medical term itself, but it refers to a specific species of African clawed frog that is often used in scientific research, including biomedical and developmental studies. Therefore, its relevance to medicine comes from its role as a model organism in laboratories.

In a broader sense, Xenopus laevis has contributed significantly to various medical discoveries, such as the understanding of embryonic development, cell cycle regulation, and genetic research. For instance, the Nobel Prize in Physiology or Medicine was awarded in 1963 to John R. B. Gurdon and Sir Michael J. Bishop for their discoveries concerning the genetic mechanisms of organism development using Xenopus laevis as a model system.

Thiazides are a class of diuretic drugs that promote the excretion of salt and water from the body by inhibiting the reabsorption of sodium and chloride ions in the distal convoluted tubule of the nephron in the kidney. Chemically, thiazides contain a sulfonamide group and a benzothiadiazine ring.

Thiazide diuretics are widely used in the treatment of hypertension (high blood pressure), heart failure, and edema (fluid retention) associated with various medical conditions such as liver cirrhosis, kidney disease, and nephrotic syndrome. Examples of thiazide diuretics include hydrochlorothiazide, chlorthalidone, indapamide, and metolazone.

It is important to note that while thiazides are effective in reducing fluid volume and blood pressure, they can also cause electrolyte imbalances, including hypokalemia (low potassium levels), hyponatremia (low sodium levels), and hypercalcemia (high calcium levels). Therefore, patients taking thiazide diuretics should be monitored closely for any signs of electrolyte abnormalities.

The Loop of Henle, also known as the Henle's loop or nephron loop, is a hairpin-shaped structure in the nephrons of the mammalian kidney. It is a part of the renal tubule and plays a crucial role in concentrating urine and maintaining water-electrolyte balance in the body.

The Loop of Henle consists of two main segments: the thin descending limb, which dips into the medulla of the kidney, and the thick ascending limb, which returns to the cortex. The loop is responsible for creating a concentration gradient in the medullary interstitium, allowing for the reabsorption of water from the filtrate in the collecting ducts under the influence of antidiuretic hormone (ADH).

In summary, the Loop of Henle is a vital component of the kidney's nephron that facilitates urine concentration and helps regulate fluid balance in the body.

Preoperative care refers to the series of procedures, interventions, and preparations that are conducted before a surgical operation. The primary goal of preoperative care is to ensure the patient's well-being, optimize their physical condition, reduce potential risks, and prepare them mentally and emotionally for the upcoming surgery.

Preoperative care typically includes:

1. Preoperative assessment: A thorough evaluation of the patient's overall health status, including medical history, physical examination, laboratory tests, and diagnostic imaging, to identify any potential risk factors or comorbidities that may impact the surgical procedure and postoperative recovery.
2. Informed consent: The process of ensuring the patient understands the nature of the surgery, its purpose, associated risks, benefits, and alternative treatment options. The patient signs a consent form indicating they have been informed and voluntarily agree to undergo the surgery.
3. Preoperative instructions: Guidelines provided to the patient regarding their diet, medication use, and other activities in the days leading up to the surgery. These instructions may include fasting guidelines, discontinuing certain medications, or arranging for transportation after the procedure.
4. Anesthesia consultation: A meeting with the anesthesiologist to discuss the type of anesthesia that will be used during the surgery and address any concerns related to anesthesia risks, side effects, or postoperative pain management.
5. Preparation of the surgical site: Cleaning and shaving the area where the incision will be made, as well as administering appropriate antimicrobial agents to minimize the risk of infection.
6. Medical optimization: Addressing any underlying medical conditions or correcting abnormalities that may negatively impact the surgical outcome. This may involve adjusting medications, treating infections, or managing chronic diseases such as diabetes.
7. Emotional and psychological support: Providing counseling, reassurance, and education to help alleviate anxiety, fear, or emotional distress related to the surgery.
8. Preoperative holding area: The patient is transferred to a designated area near the operating room where they are prepared for surgery by changing into a gown, having intravenous (IV) lines inserted, and receiving monitoring equipment.

By following these preoperative care guidelines, healthcare professionals aim to ensure that patients undergo safe and successful surgical procedures with optimal outcomes.

Osmolar concentration is a measure of the total number of solute particles (such as ions or molecules) dissolved in a solution per liter of solvent (usually water), which affects the osmotic pressure. It is expressed in units of osmoles per liter (osmol/L). Osmolarity and osmolality are related concepts, with osmolarity referring to the number of osmoles per unit volume of solution, typically measured in liters, while osmolality refers to the number of osmoles per kilogram of solvent. In clinical contexts, osmolar concentration is often used to describe the solute concentration of bodily fluids such as blood or urine.

Sodium-Glucose Transporter 2 (SGLT2) is a medically recognized term referring to a specific protein that plays a crucial role in the reabsorption of glucose in the kidneys. It is a type of membrane transport protein located in the proximal convoluted tubule of the nephron, where it actively transports glucose and sodium ions from the urine back into the bloodstream.

In healthy individuals, SGLT2 is responsible for reabsorbing about 90% of the filtered glucose, maintaining normal blood glucose levels. However, in certain medical conditions like diabetes, the amount of glucose in the blood can be significantly higher than normal. As a result, SGLT2 inhibitors have been developed as a class of medications to block this transporter's function, thereby increasing glucose excretion through urine and lowering blood glucose levels.

SGLT2 inhibitors are often prescribed in combination with other diabetes medications to help manage type 2 diabetes more effectively. Common SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin.

Mannitol is a type of sugar alcohol (a sugar substitute) used primarily as a diuretic to reduce brain swelling caused by traumatic brain injury or other causes that induce increased pressure in the brain. It works by drawing water out of the body through the urine. It's also used before surgeries in the heart, lungs, and kidneys to prevent fluid buildup.

In addition, mannitol is used in medical laboratories as a medium for growing bacteria and other microorganisms, and in some types of chemical research. In the clinic, it is also used as an osmotic agent in eye drops to reduce the pressure inside the eye in conditions such as glaucoma.

It's important to note that mannitol should be used with caution in patients with heart or kidney disease, as well as those who are dehydrated, because it can lead to electrolyte imbalances and other complications.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

Bicarbonates, also known as sodium bicarbonate or baking soda, is a chemical compound with the formula NaHCO3. In the context of medical definitions, bicarbonates refer to the bicarbonate ion (HCO3-), which is an important buffer in the body that helps maintain normal pH levels in blood and other bodily fluids.

The balance of bicarbonate and carbonic acid in the body helps regulate the acidity or alkalinity of the blood, a condition known as pH balance. Bicarbonates are produced by the body and are also found in some foods and drinking water. They work to neutralize excess acid in the body and help maintain the normal pH range of 7.35 to 7.45.

In medical testing, bicarbonate levels may be measured as part of an electrolyte panel or as a component of arterial blood gas (ABG) analysis. Low bicarbonate levels can indicate metabolic acidosis, while high levels can indicate metabolic alkalosis. Both conditions can have serious consequences if not treated promptly and appropriately.

Potassium is a essential mineral and an important electrolyte that is widely distributed in the human body. The majority of potassium in the body (approximately 98%) is found within cells, with the remaining 2% present in blood serum and other bodily fluids. Potassium plays a crucial role in various physiological processes, including:

1. Regulation of fluid balance and maintenance of normal blood pressure through its effects on vascular tone and sodium excretion.
2. Facilitation of nerve impulse transmission and muscle contraction by participating in the generation and propagation of action potentials.
3. Protein synthesis, enzyme activation, and glycogen metabolism.
4. Regulation of acid-base balance through its role in buffering systems.

The normal serum potassium concentration ranges from 3.5 to 5.0 mEq/L (milliequivalents per liter) or mmol/L (millimoles per liter). Potassium levels outside this range can have significant clinical consequences, with both hypokalemia (low potassium levels) and hyperkalemia (high potassium levels) potentially leading to serious complications such as cardiac arrhythmias, muscle weakness, and respiratory failure.

Potassium is primarily obtained through the diet, with rich sources including fruits (e.g., bananas, oranges, and apricots), vegetables (e.g., leafy greens, potatoes, and tomatoes), legumes, nuts, dairy products, and meat. In cases of deficiency or increased needs, potassium supplements may be recommended under the guidance of a healthcare professional.

Dietary sodium is a mineral that is primarily found in table salt (sodium chloride) and many processed foods. It is an essential nutrient for human health, playing a crucial role in maintaining fluid balance, transmitting nerve impulses, and regulating muscle contractions. However, consuming too much dietary sodium can increase blood pressure and contribute to the development of hypertension, heart disease, stroke, and kidney problems.

The recommended daily intake of dietary sodium is less than 2,300 milligrams (mg) per day for most adults, but the American Heart Association recommends no more than 1,500 mg per day for optimal heart health. It's important to note that many processed and restaurant foods contain high levels of sodium, so it's essential to read food labels and choose fresh, whole foods whenever possible to help limit dietary sodium intake.

Sodium chloride symporter inhibitors are a class of pharmaceutical agents that block the function of the sodium chloride symporter (NCC), which is a protein found in the kidney's distal convoluted tubule. The NCC is responsible for reabsorbing sodium and chloride ions from the filtrate back into the bloodstream, helping to regulate electrolyte balance and blood pressure.

Sodium chloride symporter inhibitors work by selectively binding to and blocking the NCC, preventing it from transporting sodium and chloride ions across the cell membrane. This leads to increased excretion of sodium and chloride in the urine, which can help lower blood pressure in patients with hypertension.

Examples of sodium chloride symporter inhibitors include thiazide diuretics such as hydrochlorothiazide and chlorthalidone, which have been used for many years to treat hypertension and edema associated with heart failure and liver cirrhosis. These medications work by reducing the amount of sodium and fluid in the body, which helps lower blood pressure and reduce swelling.

It's worth noting that while sodium chloride symporter inhibitors can be effective at treating hypertension, they can also cause side effects such as electrolyte imbalances, dehydration, and increased urination. As with any medication, it's important to use them under the guidance of a healthcare provider and to follow dosing instructions carefully.

Inositol phosphates are a family of molecules that consist of an inositol ring, which is a six-carbon heterocyclic compound, linked to one or more phosphate groups. These molecules play important roles as intracellular signaling intermediates and are involved in various cellular processes such as cell growth, differentiation, and metabolism.

Inositol hexakisphosphate (IP6), also known as phytic acid, is a form of inositol phosphate that is found in plant-based foods. IP6 has the ability to bind to minerals such as calcium, magnesium, and iron, which can reduce their bioavailability in the body.

Inositol phosphates have been implicated in several diseases, including cancer, diabetes, and neurodegenerative disorders. For example, altered levels of certain inositol phosphates have been observed in cancer cells, suggesting that they may play a role in tumor growth and progression. Additionally, mutations in enzymes involved in the metabolism of inositol phosphates have been associated with several genetic diseases.

An oocyte, also known as an egg cell or female gamete, is a large specialized cell found in the ovary of female organisms. It contains half the number of chromosomes as a normal diploid cell, as it is the product of meiotic division. Oocytes are surrounded by follicle cells and are responsible for the production of female offspring upon fertilization with sperm. The term "oocyte" specifically refers to the immature egg cell before it reaches full maturity and is ready for fertilization, at which point it is referred to as an ovum or egg.

Distal kidney tubules are the final segment of the renal tubule in the nephron of the kidney. The nephron is the basic unit of the kidney that filters blood and produces urine. After the filtrate leaves the glomerulus, it enters the proximal tubule where most of the reabsorption of water, electrolytes, and nutrients occurs.

The filtrate then moves into the loop of Henle, which is divided into a thin and thick descending limb and a thin and thick ascending limb. The loop of Henle helps to establish a concentration gradient in the medullary interstitium, allowing for the reabsorption of water in the collecting ducts.

The distal tubule is the last segment of the renal tubule before the filtrate enters the collecting duct. It is a relatively short structure that receives filtrate from the thick ascending limb of the loop of Henle. The distal tubule plays an important role in regulating electrolyte and water balance by actively transporting ions such as sodium, potassium, and chloride.

The distal tubule also contains specialized cells called principal cells and intercalated cells that are responsible for secreting or reabsorbing hydrogen and potassium ions to maintain acid-base balance. Additionally, the distal tubule is a site of action for several hormones, including aldosterone, which stimulates sodium reabsorption and potassium excretion, and vasopressin (antidiuretic hormone), which promotes water reabsorption in the collecting ducts.

Diuretics are a type of medication that increase the production of urine and help the body eliminate excess fluid and salt. They work by interfering with the reabsorption of sodium in the kidney tubules, which in turn causes more water to be excreted from the body. Diuretics are commonly used to treat conditions such as high blood pressure, heart failure, liver cirrhosis, and kidney disease. There are several types of diuretics, including loop diuretics, thiazide diuretics, potassium-sparing diuretics, and osmotic diuretics, each with its own mechanism of action and potential side effects. It is important to use diuretics under the guidance of a healthcare professional, as they can interact with other medications and have an impact on electrolyte balance in the body.

Ion transport refers to the active or passive movement of ions, such as sodium (Na+), potassium (K+), chloride (Cl-), and calcium (Ca2+) ions, across cell membranes. This process is essential for various physiological functions, including nerve impulse transmission, muscle contraction, and maintenance of resting membrane potential.

Ion transport can occur through several mechanisms, including:

1. Diffusion: the passive movement of ions down their concentration gradient, from an area of high concentration to an area of low concentration.
2. Facilitated diffusion: the passive movement of ions through specialized channels or transporters in the cell membrane.
3. Active transport: the energy-dependent movement of ions against their concentration gradient, requiring the use of ATP. This process is often mediated by ion pumps, such as the sodium-potassium pump (Na+/K+-ATPase).
4. Co-transport or symport: the coupled transport of two or more different ions or molecules in the same direction, often driven by an electrochemical gradient.
5. Counter-transport or antiport: the coupled transport of two or more different ions or molecules in opposite directions, also often driven by an electrochemical gradient.

Abnormalities in ion transport can lead to various medical conditions, such as cystic fibrosis (which involves defective chloride channel function), hypertension (which may be related to altered sodium transport), and certain forms of heart disease (which can result from abnormal calcium handling).

Dicarboxylic acid transporters are a type of membrane transport protein that are responsible for the transportation of dicarboxylic acids across biological membranes. Dicarboxylic acids are organic compounds that contain two carboxyl groups, and they play important roles in various metabolic processes within the body.

The sodium-dependent dicarboxylic acid transporters (NaDCs) are a subfamily of these transporters that are widely expressed in many tissues, including the kidney, intestine, and brain. NaDCs mediate the uptake of dicarboxylates, such as succinate and glutarate, into cells in an energy-dependent manner, using the gradient of sodium ions across the membrane to drive the transport process.

The other subfamily of dicarboxylic acid transporters are the proton-coupled dicarboxylate transporters (PCDTs), which use a proton gradient to transport dicarboxylates. These transporters play important roles in the absorption and metabolism of dietary fibers, as well as in the regulation of intracellular pH.

Defects in dicarboxylic acid transporters have been implicated in several human diseases, including renal tubular acidosis, a condition characterized by impaired ability to excrete hydrogen ions and reabsorb bicarbonate ions in the kidney.

Organic anion transporters (OATs) are membrane transport proteins that facilitate the movement of organic anions across biological membranes. The term "sodium-dependent" refers to a specific type of OAT that requires sodium ions (Na+) as a co-transport substrate to move organic anions across the membrane. These transporters play crucial roles in the elimination and distribution of various endogenous and exogenous organic anions, including drugs, toxins, and metabolites. Sodium-dependent OATs are primarily located in the kidneys and liver, where they help maintain homeostasis by regulating the reabsorption and secretion of these substances.

Monosaccharide transport proteins are a type of membrane transport protein that facilitate the passive or active transport of monosaccharides, such as glucose, fructose, and galactose, across cell membranes. These proteins play a crucial role in the absorption, distribution, and metabolism of carbohydrates in the body.

There are two main types of monosaccharide transport proteins: facilitated diffusion transporters and active transporters. Facilitated diffusion transporters, also known as glucose transporters (GLUTs), passively transport monosaccharides down their concentration gradient without the need for energy. In contrast, active transporters, such as the sodium-glucose cotransporter (SGLT), use energy in the form of ATP to actively transport monosaccharides against their concentration gradient.

Monosaccharide transport proteins are found in various tissues throughout the body, including the intestines, kidneys, liver, and brain. They play a critical role in maintaining glucose homeostasis by regulating the uptake and release of glucose into and out of cells. Dysfunction of these transporters has been implicated in several diseases, such as diabetes, cancer, and neurological disorders.

Defecation is the medical term for the act of passing stools (feces) through the anus. It is a normal bodily function that involves the contraction of muscles in the colon and anal sphincter to release waste from the body. Defecation is usually a regular and daily occurrence, with the frequency varying from person to person.

The stool is made up of undigested food, bacteria, and other waste products that are eliminated from the body through the rectum and anus. The process of defecation is controlled by the autonomic nervous system, which regulates involuntary bodily functions such as heart rate and digestion.

Difficulties with defecation can occur due to various medical conditions, including constipation, irritable bowel syndrome, and inflammatory bowel disease. These conditions can cause symptoms such as hard or painful stools, straining during bowel movements, and a feeling of incomplete evacuation. If you are experiencing any problems with defecation, it is important to speak with your healthcare provider for proper diagnosis and treatment.

High-performance liquid chromatography (HPLC) is a type of chromatography that separates and analyzes compounds based on their interactions with a stationary phase and a mobile phase under high pressure. The mobile phase, which can be a gas or liquid, carries the sample mixture through a column containing the stationary phase.

In HPLC, the mobile phase is a liquid, and it is pumped through the column at high pressures (up to several hundred atmospheres) to achieve faster separation times and better resolution than other types of liquid chromatography. The stationary phase can be a solid or a liquid supported on a solid, and it interacts differently with each component in the sample mixture, causing them to separate as they travel through the column.

HPLC is widely used in analytical chemistry, pharmaceuticals, biotechnology, and other fields to separate, identify, and quantify compounds present in complex mixtures. It can be used to analyze a wide range of substances, including drugs, hormones, vitamins, pigments, flavors, and pollutants. HPLC is also used in the preparation of pure samples for further study or use.

Temperature, in a medical context, is a measure of the degree of hotness or coldness of a body or environment. It is usually measured using a thermometer and reported in degrees Celsius (°C), degrees Fahrenheit (°F), or kelvin (K). In the human body, normal core temperature ranges from about 36.5-37.5°C (97.7-99.5°F) when measured rectally, and can vary slightly depending on factors such as time of day, physical activity, and menstrual cycle. Elevated body temperature is a common sign of infection or inflammation, while abnormally low body temperature can indicate hypothermia or other medical conditions.

Furosemide is a loop diuretic medication that is primarily used to treat edema (fluid retention) associated with various medical conditions such as heart failure, liver cirrhosis, and kidney disease. It works by inhibiting the sodium-potassium-chloride cotransporter in the ascending loop of Henle in the kidneys, thereby promoting the excretion of water, sodium, and chloride ions. This increased urine output helps reduce fluid accumulation in the body and lower blood pressure.

Furosemide is also known by its brand names Lasix and Frusid. It can be administered orally or intravenously, depending on the patient's condition and the desired rate of diuresis. Common side effects include dehydration, electrolyte imbalances, hearing loss (in high doses), and increased blood sugar levels.

It is essential to monitor kidney function, electrolyte levels, and fluid balance while using furosemide to minimize potential adverse effects and ensure appropriate treatment.

Calcium is an essential mineral that is vital for various physiological processes in the human body. The medical definition of calcium is as follows:

Calcium (Ca2+) is a crucial cation and the most abundant mineral in the human body, with approximately 99% of it found in bones and teeth. It plays a vital role in maintaining structural integrity, nerve impulse transmission, muscle contraction, hormonal secretion, blood coagulation, and enzyme activation.

Calcium homeostasis is tightly regulated through the interplay of several hormones, including parathyroid hormone (PTH), calcitonin, and vitamin D. Dietary calcium intake, absorption, and excretion are also critical factors in maintaining optimal calcium levels in the body.

Hypocalcemia refers to low serum calcium levels, while hypercalcemia indicates high serum calcium levels. Both conditions can have detrimental effects on various organ systems and require medical intervention to correct.

Glyceraldehyde 3-phosphate (G3P) is a crucial intermediate in both glycolysis and gluconeogenesis metabolic pathways. It is an triose sugar phosphate, which means it contains three carbon atoms and has a phosphate group attached to it.

In the glycolysis process, G3P is produced during the third step of the process from the molecule dihydroxyacetone phosphate (DHAP) via the enzyme triosephosphate isomerase. In the following steps, G3P is converted into 1,3-bisphosphoglycerate, which eventually leads to the production of ATP and NADH.

In gluconeogenesis, G3P is produced from the reverse reaction of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase, using the molecule dihydroxyacetone phosphate (DHAP) as a starting point. G3P is then converted into glucose-6-phosphate, which can be further metabolized or released from the cell.

It's important to note that Glyceraldehyde 3-Phosphate plays a key role in energy production and carbohydrate metabolism.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

Sodium-glucose transport proteins (SGLTs) are a group of membrane transporters that facilitate the active transport of glucose across cell membranes in various tissues, including the kidneys and intestines. They function by coupling the movement of glucose molecules with sodium ions, using the energy generated by the sodium gradient across the membrane.

The two main types of SGLTs are:

1. SGLT1: This transporter is primarily found in the intestines and plays a crucial role in glucose absorption from food. It has a high affinity for glucose and transports it along with sodium ions, which helps create an electrochemical gradient that drives the transport process.

2. SGLT2: This transporter is mainly located in the early proximal tubules of the kidneys and is responsible for reabsorbing about 90% of the filtered glucose back into the bloodstream. It has a lower affinity for glucose compared to SGLT1 but operates at a higher transport rate, allowing it to efficiently reabsorb large amounts of glucose.

Inhibitors of SGLT2, known as SGLT2 inhibitors or gliflozins, have been developed for the treatment of type 2 diabetes. By blocking SGLT2-mediated glucose reabsorption in the kidneys, these medications promote urinary glucose excretion and help lower blood glucose levels. Examples of SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

... an analogue sodium phosphate cotransporter protein. Symptoms include renal phosphate wasting in addition to increase levels of ... Sodium-dependent phosphate transport protein 2C is a protein that in humans is encoded by the SLC34A3 gene. SLC34A3 contributes ... rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate ... "Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene ...
This gene encodes a member of the type II sodium-phosphate cotransporter family. The sodium/phosphate cotransporter is a ... Sodium-dependent phosphate transport protein 2A, also known as Na+-Pi cotransporter 2a (NaPi-2a), is a protein in humans that ... Sodium-Phosphate+Cotransporter+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH) v t e ( ... into the cell along with 3 sodium ions. Alternatively it can move dihydrogen phosphate (H2PO4− along with 2 sodium ions. For ...
January 2006). "Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal ... Secreted frizzled-related protein 4 is a protein that in humans is encoded by the SFRP4 gene. Secreted frizzled-related protein ... "Entrez Gene: SFRP4 secreted frizzled-related protein 4". Kiper PO, Saito H, Gori F, Unger S, Hesse E, Yamana K, et al. (June ... Schumann H, Holtz J, Zerkowski HR, Hatzfeld M (February 2000). "Expression of secreted frizzled related proteins 3 and 4 in ...
Collins JF, Bai L, Ghishan FK (February 2004). "The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters ... Murer H, Forster I, Biber J (February 2004). "The sodium phosphate cotransporter family SLC34" (PDF). Pflügers Archiv. 447 (5 ... sugar-phosphate/phosphate exchanger (SLC37A1, SLC37A2, SLC37A3, SLC37A4) System A & N, sodium-coupled neutral amino acid ... Markovich D, Murer H (February 2004). "The SLC13 gene family of sodium sulphate/carboxylate cotransporters". Pflügers Archiv. ...
Na+/phosphate cotransporter (NaPi) - Sodium-phosphate cotransporters are from the SLC34 and SLC20 protein families. They are ... Na-K-2Cl symporter K-Cl cotransporter Sodium/phosphate cotransporter Sodium-glucose transport proteins Glucose transporter ... Na+/glucose cotransporter (SGLT1) - is also known as sodium-glucose cotransporter 1 and is encoded by the SLC5A1 gene. SGLT1 is ... The NKCC1 cotransport protein is found throughout the body but NKCC2 is found only in the kidney and removes the sodium, ...
... sodium-phosphate cotransporter proteins MeSH D12.776.543.585.450.625.625.500 - sodium-phosphate cotransporter proteins, type i ... sodium-phosphate cotransporter proteins MeSH D12.776.543.585.450.074.750.750.500 - sodium-phosphate cotransporter proteins, ... sodium-phosphate cotransporter proteins, type ii MeSH D12.776.543.585.450.074.750.750.750.124 - sodium-phosphate cotransporter ... sodium-phosphate cotransporter proteins, type iib MeSH D12.776.543.585.450.074.750.750.750.500 - sodium-phosphate cotransporter ...
"Regulation of the human sodium-phosphate cotransporter NaP(i)-IIb gene promoter by epidermal growth factor". American Journal ... Sodium-dependent phosphate transport protein 2B (NaPi2b) is a protein that in humans is encoded by the SLC34A2 gene. Sodium- ... "Entrez Gene: SLC34A2 solute carrier family 34 (sodium phosphate), member 2". Yin BW, Kiyamova R, Chua R, Caballero OL, Gout I, ... dependent phosphate transport protein 2b (NaPi2b) is a tumor-associated antigen. As of April 2023, upifitamab rilsodotin, an ...
... the sodium phosphate co-transporter, and 12 of the 13 exons located within the gene encode this co-transporter. Type II ... protein that is expressed primarily in the apical portions of alveolar type II cells and is the most abundant phosphate carrier ... Mutations in the gene SLC34A2 result in loss of a key sodium, phosphate co-transporter (called Npt2b), known to be expressed in ... "The autozygous segments predicted by a genome-wide SNP typing revealed mutations in the type IIb sodium phosphate cotransporter ...
1995). "Cloning and functional expression of a Na(+)-dependent phosphate co-transporter from human kidney: cDNA cloning and ... Sodium-dependent phosphate transport protein 1 is a protein that in humans is encoded by the SLC17A1 gene. Solute carrier ... "Molecular cloning of the cDNA encoding a human renal sodium phosphate transport protein and its assignment to chromosome 6p21.3 ... "Entrez Gene: SLC17A1 solute carrier family 17 (sodium phosphate), member 1". Miyamoto K, Tatsumi S, Sonoda T, et al. ( ...
The protein encoded by this gene is a vesicle-bound, sodium-dependent phosphate transporter that is specifically expressed in ... The protein shares 82% identity with the differentiation-associated Na-dependent inorganic phosphate cotransporter and they ... "Entrez Gene: SLC17A7 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7". Bellocchio EE, ... dependent inorganic phosphate cotransporter". J Neurochem. 66 (6): 2227-38. doi:10.1046/j.1471-4159.1996.66062227.x. PMID ...
... sodium-phosphate cotransporter proteins MeSH D12.776.157.530.450.625.625.500 - sodium-phosphate cotransporter proteins, type i ... sodium-phosphate cotransporter proteins MeSH D12.776.157.648.500.750.500 - sodium-phosphate cotransporter proteins, type i MeSH ... sodium-phosphate cotransporter proteins, type ii MeSH D12.776.157.648.500.750.750.124 - sodium-phosphate cotransporter proteins ... sodium-phosphate cotransporter proteins, type iic MeSH D12.776.157.648.500.750.875 - sodium-phosphate cotransporter proteins, ...
"Entrez Gene: solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter)". Online Mendelian Inheritance in ... The encoded protein transports the neurotransmitter glutamate into synaptic vesicles before it is released into the synaptic ... Vesicular glutamate transporter 3 (VGLUT3) is a protein that in humans is encoded by the SLC17A8 gene. This gene encodes a ... 2007). "Docking and homology modeling explain inhibition of the human vesicular glutamate transporters". Protein Sci. 16 (9): ...
FGF23 acts on the kidneys by decreasing the expression of NPT2, a sodium-phosphate cotransporter in the proximal tubule. FGF23 ... This putative protein was known as phosphatonin. Several types of effects were described including impairment of sodium ... It does this by decreasing reabsorption of phosphate in the kidney, which means phosphate is excreted in urine. FGF23 is ... 23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway". The Journal of ...
As a typical kinase, WNK4 accomplishes the phosphorylation of its substrate proteins by adding a phosphate moiety in an ATP- ... which in turn can phosphorylate and activate the thiazide-sensitive sodium-chloride cotransporter (NCC) (Fig. 2). Similarly, ... The increase in sodium reabsorption in this segment of the nephron reduces the sodium load in the collecting duct, where sodium ... Serine/threonine protein kinase WNK4 also known as WNK lysine deficient protein kinase 4 or WNK4, is an enzyme that in humans ...
These proteins may include sodium-potassium-2 chloride co-transporter, chloride anion exchangers, and chloride channels. ... In the 1st phase, organic solutes (such as phosphates, amino acids, glucose and anions), sodium ions, and hydronium ions are ... due to increased sodium chloride intake Edema - due to influx in sodium in the body Weakness - due to loss of fluids Thirst - ... or increased administration of sodium chloride. These abnormalities are caused by diarrhea, vomiting, increased sodium chloride ...
Unlike for glucose, there is no transport protein for glucose-6-phosphate. Gluconeogenesis allows the organism to build up ... transporters via a secondary active transport mechanism called sodium ion-glucose symport via sodium/glucose cotransporter 1 ( ... are probably due to the glycation of proteins or lipids. In contrast, enzyme-regulated addition of sugars to protein is called ... In dilute sodium hydroxide or other dilute bases, the monosaccharides mannose, glucose and fructose interconvert (via a Lobry ...
... encoding protein single-minded homolog 2 SLC5A3: encoding protein sodium/myo-inositol cotransporter SLC19A1: encoding protein ... encoding enzyme 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma AIRE: encoding protein autoimmune regulator APP: encoding ... encoding protein encoding protein encoding protein Trafficking protein particle complex subunit 10 TMPRSS2: encoding enzyme ... encoding protein GC-rich sequence DNA-binding factor homolog PCBP3: encoding poly(rC)-binding protein 3 PCNT: encoding protein ...
... phosphate. The generalized transport reaction catalyzed by the DASS family proteins is probably: Anion2− (out) + nM+ [Na+ or H+ ... Markovich D (2012-01-01). "Sodium-sulfate/carboxylate cotransporters (SLC13)". Current Topics in Membranes. 70: 239-56. doi: ... Portal: Biology (CS1: long volume value, Protein pages needing a picture, Protein families, Solute carrier family). ... a functionally uncharacterized protein from Ralstonia eutrophus; three E. coli proteins plus one from H. influenzae and one ...
... was associated with decreased apical expression of the sodium/phosphate cotransporter NaPi2a that is the predominant phosphate ... for the NH2-terminal extended 816 amino acid protein and one does not encode for any protein (Transcript variant 5, [NM_ ... stabilization and disassembly of the endocytic complex via protein-protein interactions. Therefore, ClC-5 may accomplish two ... CLCN5+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Human CLCN5 genome location and ...
These 3 proteins show no homology to one another at the DNA or protein level. GLVR1 is a sodium-dependent phosphate symporter.[ ... Li X, Yang HY, Giachelli CM (2006). "Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle ... Sodium-dependent phosphate transporter 1 is a protein that in humans is encoded by the SLC20A1 gene. Retrovirus receptors allow ... 1998). "Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid ...
December 2018). "Simple yet functional phosphate-loop proteins". Proceedings of the National Academy of Sciences of the United ... An important example is the sodium-potassium pump (Na+/K+ATPase) that maintains the cell membrane potential. Another example is ... Besides exchangers, other categories of transmembrane ATPase include co-transporters and pumps (however, some exchangers are ... ATP13A5 ATP synthase ATP synthase alpha/beta subunits AAA proteins P-ATPase Geider K, Hoffmann-Berling H (1981). "Proteins ...
... increases the activity of a sodium-hydrogen exchange protein in the kidney. This increases the retention of sodium ions whilst ... Decreases in albumin and phosphate will cause metabolic alkalosis. Retention of bicarbonate - Retention of bicarbonate would ... inactivating the NKCC2 cotransporter, creating a Bartter's syndrome like effect. Compensation for metabolic alkalosis occurs ... Milk alkali syndrome Blood product administration since this contains sodium citrate which is then metabolized into sodium ...
An amino acid transporter is a membrane transport protein that transports amino acids. They are mainly of the solute carrier ... Reimer RJ, Edwards RH (2004). "Organic anion transport is the primary function of the SLC17/type I phosphate transporter family ... Mackenzie B, Erickson JD (2004). "Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family". ... Daniel H, Kottra G (2004). "The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology". Pflügers Arch. ...
Many of the corresponding kidney specific proteins are expressed in the cell membrane and function as transporter proteins. The ... On the basal side of the cell there is a HCO3/Cl exchanger and a Cl/K co-transporter (facilitated diffusion). When the reaction ... Amino acids are reabsorbed by sodium dependent transporters in the proximal tubule. Hartnup disease is a deficiency of the ... promotes intestinal absorption of calcium and the renal reabsorption of phosphate. Renin is an enzyme which regulates ...
Substances reabsorbed in the PCT include urea, water, potassium, sodium, chloride, glucose, amino acids, lactate, phosphate, ... blood in the vasa recta still has large proteins and ions which were not filtered through the glomerulus. This provides an ... ions are reabsorbed from the urine by secondary active transport by a Na-K-Cl cotransporter (NKCC2). The electrical and ... Ascending limb of loop of Henle Sodium (Na+), potassium (K+) and chloride (Cl−) ...
Family 2.A.20 The Inorganic Phosphate Transporter (PiT) Family 2.A.21 Solute:Sodium Symporter Family 2.A.22 The ... HBV-S Protein) Family 1.G.7 The Reovirus FAST Fusion Protein (R-FAST) Family 1.G.8 The Arenavirus Fusion Protein (AV-FP) Family ... Co-transporter (IDC) Family 2.B.18 The Pyridine-2,6-Dicarboxamine Derivative (PDCA) H+:Cl− Co-transporter Family 2.B.19 The ... Transport proteins, Transmembrane proteins, Protein classification, Biological databases). ...
Li X, Giachelli CM (2007). "Sodium-dependent phosphate cotransporters and vascular calcification". Curr. Opin. Nephrol. ... PIT1+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Transcription+Factor+Pit-1 at the ... Bamberger AM, Bamberger CM, Pu LP, Puy LA, Loh YP, Asa SL (1995). "Expression of pit-1 messenger ribonucleic acid and protein ... PIT1 contains 2 protein domains, termed POU-specific and POU-homeo, which are both necessary for high affinity DNA binding on ...
Cotransport Cotransporter Sodium-glucose transport proteins Glucose transporter Oral rehydration therapy Robert K. Crane. " ... "The relationship of mitochondrial phosphate to aerobic phosphate bond generation". Journal of Biological Chemistry 201, 1953, ... Half a century later this idea has turned into one of the most studied of all transporter proteins (SGLT1), the sodium-glucose ... will] develop a chemical process to achieve synthesis of a new class of Sodium Glucose Cotransporters inhibitors (...), for the ...
In rats with diabetes insipidus, thiazide diuretics inhibit the NaCl cotransporter in the renal distal convoluted tubule, ... phosphate in urine) Glycosuria (glucose in urine) Kaliuresis (potassium in urine) Hyperuricosuria (excessive amounts of uric ... while increasing the reabsorption of calcium in this segment in a manner unrelated to sodium transport. Amiloride also ... a 746-amino-acid protein (CLC-5) with 12 to 13 transmembrane domains. It manifests itself through low-molecular-weight ...
Half a century later this idea has turned into one of the most studied of all transporter proteins (SGLT1), the sodium-glucose ... One category of cotransporters that is especially prominent in research regarding diabetes treatment is sodium-glucose ... Hydrolysis of the bound phosphate group and release of hydrogen ion then restores the carrier to its original conformation. P- ... For example, the sodium-potassium pump uses ATP to pump sodium ions out of the cell and potassium ions into the cell, ...
SLC34A1 protein, human * Slc34a1 protein, mouse * Sodium-Phosphate Cotransporter Proteins * Sodium-Phosphate Cotransporter ... The renal phosphate wasting in the transgenic mice was accompanied by the reduced expression of sodium phosphate cotransporter ... FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa ... 23 reproduced the common clinical features of these diseases such as hypophosphatemia probably due to increased renal phosphate ...
... an analogue sodium phosphate cotransporter protein. Symptoms include renal phosphate wasting in addition to increase levels of ... Sodium-dependent phosphate transport protein 2C is a protein that in humans is encoded by the SLC34A3 gene. SLC34A3 contributes ... rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate ... "Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene ...
... of a compound called calcium phosphate gradually accumulate in the small air sacs (alveoli) located throughout the lungs. ... This gene provides instructions for making a protein called the type IIb sodium-phosphate cotransporter, which plays a role in ... Research suggests that the type IIb sodium-phosphate cotransporter normally helps clear this phosphate. SLC34A2 gene mutations ... are thought to impair the activity of the type IIb sodium-phosphate cotransporter, resulting in the accumulation of phosphate ...
Hypophosphatemia is defined as a phosphate level of less than 2.5 mg/dL (0. ... 12] In the proximal tubule, phosphate reabsorption by type 2 sodium phosphate cotransporters is regulated by dietary phosphate ... Several sodium-coupled transport proteins have been identified that enable intracellular uptake of phosphate by taking ... Type 1 sodium phosphate cotransporters are expressed predominantly in kidney cells on the apical membranes of proximal tubule ...
Type III Sodium-Phosphate Cotransporter Proteins 100% * Endosomal Sorting Complexes Required for Transport 75% ... Cellular abundance of sodium phosphate cotransporter SLC20A1/PiT1 and phosphate uptake are controlled post-transcriptionally by ...
... primary transport protein responsible for phosphate reabsorption in the kidney is the type II sodium-phosphate cotransporter ( ... In TIO most tumors overexpress the protein fibroblast growth factor-23 (FGF-23) inhibiting renal phosphate reabsorption in the ... The level of phosphate was slightly decreased with 2.14 mg/dL, and an oral substitution was restarted. The level of phosphate ... A 24-hour urine sample revealed an increased phosphate clearance of 44.7 mL/min (normal range: 5-16 mL/min). Fractional ...
... decreased phosphate excretion, or a disorder that shifts intracellular phosphate to extracellular space. (See Pathophysiology, ... an abnormally high serum phosphate level, can result from increased phosphate (PO4) intake, ... The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. Pflugers Arch. 2004. 447: ... Phosphate absorption in the remainder of the nephron is generally mediated by type 3 sodium phosphate cotransporters. No direct ...
... sodium-glucose co-transporter 2; NaPi-IIa/c, sodium-phosphate co-transporter IIa/c; GLUT2, glucose transporter 2. ... PTC, proximal tubule cell; VDBP, vitamin D binding protein; SGLT2, sodium-glucose co-transporter 2; NaPi-IIa/c, sodium- ... Excess of sodium boosts phosphate reabsorption via SLC34A1 (NaPi-IIa) and SLC34A3 (NaPi-IIc) co-transporters, and increased ... and translocation of sodium-phosphate co-transporters in the proximal tubule [35, 36]. 1,25(OH)2D itself inhibits CYP27B1 ...
Anion Transport Proteins. Phosphate Transport Proteins. Proton-Phosphate Symporters. Sodium-Phosphate Cotransporter Proteins ...
Dysfunctions in tubular phosphate reabsorption via the sodium-phosphate cotransporter, endocytotic reabsorption of the vitamin ... a phosphate-regulating gene with homologies to endopeptidases on the X chromosome) and dentin matrix protein 1 (DMP1), ... Mutations in the gene that codes for the main renal sodium-phosphate cotransporter (NPT2a) have been reported in some patients ... Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation ...
Sodium-dependent phosphate transport protein 2A; Sodium-phosphate transport protein 2A; sodium/phosphate co-transporter; Sodium ... Protein Aliases: Na(+)-dependent phosphate cotransporter 2A; Na(+)/Pi cotransporter 2A; Na+-phosphate cotransporter type II; ... phosphate cotransporter 2A; solute carrier family 17 (sodium phosphate), member 2; solute carrier family 34 (sodium phosphate ... inorganic phosphate transmembrane transporter activity sodium:phosphate symporter activity protein binding sodium-dependent ...
Sodium-phosphate transport protein 2B; AltName: Full=Na(+)-dependent phosphate cotransporter 2B; AltName: Full=Sodium/phosphate ... Sodium-phosphate transport protein 2A; AltName: Full=Na(+)-dependent phosphate cotransporter 2A; AltName: Full=Sodium/phosphate ... Sodium-phosphate transport protein 2B; AltName: Full=Na(+)-dependent phosphate cotransporter 2B; AltName: Full=Sodium/phosphate ... Sodium-phosphate transport protein 2A; AltName: Full=Na(+)-dependent phosphate cotransporter 2A; AltName: Full=Sodium/phosphate ...
Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.157.530.937.704] * Sodium-Phosphate Cotransporter Proteins, Type III ... Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.543.585.937.829] * Sodium-Phosphate Cotransporter Proteins, Type III ... Proteins [D12.776] * Carrier Proteins [D12.776.157] * Membrane Transport Proteins [D12.776.157.530] * Solute Carrier Proteins [ ... Proteins [D12.776] * Membrane Proteins [D12.776.543] * Membrane Transport Proteins [D12.776.543.585] * Solute Carrier Proteins ...
The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. ... Phosphate transport. The main phosphate transporter family is the sodium-dependent phosphate cotransporter, also known as NaPi ... Subsequent studies have shown43 that PFA is not an effective inhibitor of sodium-phosphate co-transporter type III (Pit1 and ... Role of the sodium-dependent phosphate cotransporter Pit-1, in vascular smooth muscle cell calcification. ...
... neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters ... Vesicular Neurotransmitter Transport Proteins [D12.776.157.530.450.162.887]. *Vesicular Glutamate Transport Proteins [D12.776. ... Vesicular Neurotransmitter Transport Proteins [D12.776.543.585.450.162.887]. *Vesicular Glutamate Transport Proteins [D12.776. ... Vesicular Neurotransmitter Transport Proteins [D12.776.157.530.562.750]. *Vesicular Glutamate Transport Proteins [D12.776. ...
Sodium-dependent phosphate transport protein 2B, Sodium-phosphate transport protein 2B, Sodium/phosphate cotransporter 2B, ... Overview: The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is ... Synonyms: Na (+) -dependent phosphate cotransporter 2B, Na (+) /Pi cotransporter 2B, NaPi-2b, NaPi3b, NPT2B, SLC34A2, ...
Sodium phosphate dodecahydrate. CAS Number: 10101-89-0. Catalog Number: AA0003FT. MDL Number: MFCD00003510. Molecular Formula: ... Title: Evaluation of a dehydrated beef protein to replace sodium-based phosphates in injected beef strip loins.. Journal: Meat ... Title: Partitioning of NaPi cotransporter in cholesterol-, sphingomyelin-, and glycosphingolipid-enriched membrane domains ... Title: Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal ...
NaPi 1 Proteins use Sodium-Phosphate Cotransporter Proteins, Type I NaPi-1 Proteins use Sodium-Phosphate Cotransporter Proteins ... NaCl KCl Cotransporter use Sodium-Potassium-Chloride Symporters NaCl-KCl Cotransporter use Sodium-Potassium-Chloride Symporters ... Na(+)-SO4(2-) Cotransporter use Sodium Sulfate Cotransporter Na+ Independent Neutral Amino Acid Transporter use Amino Acid ... Na(+) K(+)-Transporting ATPase use Sodium-Potassium-Exchanging ATPase Na(+), K(+), Cl(-)-Cotransporter use Sodium-Potassium- ...
Protein expression levels of the sodium/glucose cotransporter 2 (SGLT2), GLUT1, GLUT5, the nicotinamide adenine dinucleotide ... METHODS AND RESULTS: Treatment with oral CoQ10 for 4 weeks abolished nicotinamide adenine dinucleotide phosphate-oxidase (NADPH ... Sodium glucose cotransporter 2 (SGLT2) inhibitor, also known as dapagliflozin (Dapa) can be used to treat diabetes. Here, we ... Sodium-glucose cotransporter 2 (SGLT2), glucose transporter 1 (GLUT1), GLUT5, the reduced form of nicotinamide adenine ...
Sodium-Glucose Transport Proteins. *Sodium-Phosphate Cotransporter Proteins. *Sodium-Potassium-Chloride Symporters ... "Sodium-Potassium-Chloride Symporters" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, ... This graph shows the total number of publications written about "Sodium-Potassium-Chloride Symporters" by people in this ... A subclass of symporters that specifically transport SODIUM CHLORIDE and POTASSIUM CHLORIDE across cellular membranes in a ...
NaPi 1 Proteins use Sodium-Phosphate Cotransporter Proteins, Type I NaPi-1 Proteins use Sodium-Phosphate Cotransporter Proteins ... NaCl KCl Cotransporter use Sodium-Potassium-Chloride Symporters NaCl-KCl Cotransporter use Sodium-Potassium-Chloride Symporters ... Na(+)-SO4(2-) Cotransporter use Sodium Sulfate Cotransporter Na+ Independent Neutral Amino Acid Transporter use Amino Acid ... Na(+) K(+)-Transporting ATPase use Sodium-Potassium-Exchanging ATPase Na(+), K(+), Cl(-)-Cotransporter use Sodium-Potassium- ...
NaPi 1 Proteins use Sodium-Phosphate Cotransporter Proteins, Type I NaPi-1 Proteins use Sodium-Phosphate Cotransporter Proteins ... NaCl KCl Cotransporter use Sodium-Potassium-Chloride Symporters NaCl-KCl Cotransporter use Sodium-Potassium-Chloride Symporters ... Na(+) K(+)-Transporting ATPase use Sodium-Potassium-Exchanging ATPase Na(+), K(+), Cl(-)-Cotransporter use Sodium-Potassium- ... N WASP Protein use Wiskott-Aldrich Syndrome Protein, Neuronal N WASP Wiskott Aldrich Syndrome Protein use Wiskott-Aldrich ...
NaPi 1 Proteins use Sodium-Phosphate Cotransporter Proteins, Type I NaPi-1 Proteins use Sodium-Phosphate Cotransporter Proteins ... NaCl KCl Cotransporter use Sodium-Potassium-Chloride Symporters NaCl-KCl Cotransporter use Sodium-Potassium-Chloride Symporters ... Na(+) K(+)-Transporting ATPase use Sodium-Potassium-Exchanging ATPase Na(+), K(+), Cl(-)-Cotransporter use Sodium-Potassium- ... N WASP Protein use Wiskott-Aldrich Syndrome Protein, Neuronal N WASP Wiskott Aldrich Syndrome Protein use Wiskott-Aldrich ...
NaPi 1 Proteins use Sodium-Phosphate Cotransporter Proteins, Type I NaPi-1 Proteins use Sodium-Phosphate Cotransporter Proteins ... NaCl KCl Cotransporter use Sodium-Potassium-Chloride Symporters NaCl-KCl Cotransporter use Sodium-Potassium-Chloride Symporters ... Na(+) K(+)-Transporting ATPase use Sodium-Potassium-Exchanging ATPase Na(+), K(+), Cl(-)-Cotransporter use Sodium-Potassium- ... N WASP Protein use Wiskott-Aldrich Syndrome Protein, Neuronal N WASP Wiskott Aldrich Syndrome Protein use Wiskott-Aldrich ...
Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.157.530.937.704] * Sodium-Phosphate Cotransporter Proteins, Type III ... Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.543.585.937.829] * Sodium-Phosphate Cotransporter Proteins, Type III ... Proteins [D12.776] * Carrier Proteins [D12.776.157] * Membrane Transport Proteins [D12.776.157.530] * Solute Carrier Proteins [ ... Proteins [D12.776] * Membrane Proteins [D12.776.543] * Membrane Transport Proteins [D12.776.543.585] * Solute Carrier Proteins ...
Sodium Phosphate Dibasic Heptahydrate ACS/USP Granular is Jost Chemical product code 2781 and CAS Number 7782-85-6, granular. ... a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter ... Advanced glycation end products and S100 proteins interact with the receptor for advanced glycation end products (RAGE). In the ... Home › Products › SodiumSodium Phosphate Dibasic Heptahydrate, ACS/USP Granular. Sodium Phosphate Dibasic Heptahydrate, ACS/ ...
... a G protein-coupled receptor) signalling pathway; and the metabolic pathways for vitamin D, oxalate, cysteine, purines and uric ... Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2 A cause idiopathic infantile hypercalcemia. ... Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J. Biol. Chem. 276, 9206-9213 (2001). ... the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate ...
Effects of Halothane on Sodium-dependent Uptake of Phosphate and Alanine. Uptake of phosphate and alanine was not modified by ... These cotransporters are a common route of amino acids and phosphate entry into the cells but only account for 13% of total Na ... Uptake of phosphate, alanine, Na, and Rb was expressed as nanomoles per milligram of protein. For evaluation of the recovery, ... Clerici C, Soler P, Saumon G: Sodium-dependent phosphate and alanine transports but sodium-independent hexose transport in type ...
2002). The nptA gene of Vibrio cholerae encodes a functional sodium-dependent phosphate cotransporter homologous to the type II ... View Proteins belonging to: The Phosphate:Na+ Symporter (PNaS) Family. References associated with 2.A.58 family:. Bakouh, N., B ... 2015). Identification of the First Sodium Binding Site of the Phosphate Cotransporter NaPi-IIa (SLC34A1). Biophys. J. 108: 2465 ... 2016). Characterizing and evaluating the expression of the type IIb sodium-dependent phosphate cotransporter (slc34a2) gene and ...
  • SLC34A3 contributes to the maintenance of inorganic phosphate concentration at the kidney. (wikipedia.org)
  • Vascular smooth muscle cells are sensitive to changes in inorganic phosphate (Pi) levels. (revistanefrologia.com)
  • A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. (uchicago.edu)
  • The PNaS family includes several functionally characterized, sodium-dependent, inorganic phosphate (P i ) transporter (NPT2 or NptA) proteins from mammals. (tcdb.org)
  • Mammalian porters of the PNaS family may catalyze cotransport of 3 Na + with 1 inorganic phosphate. (tcdb.org)
  • In response to parathyroid hormone and dietary inorganic phosphate, the renal cotransporter is rapidly inserted into and retrieved from the renal brush border membrane in a fashion similar to that by which the glucose transporter (Glut4) (TC# 2.A.1.1) is regulated by insulin, and aquaporins 1 and 2 (TC# 1.A.8.1) are regulated by vasopressin (Levi et al. (tcdb.org)
  • Inadequate levels of inorganic phosphate impair, bone matrix ossification because the formation of mature bone involves the precipitation of hydroxyapatite [calcium phosphate salt] crystals. (boneandspine.com)
  • Sodium-Potassium-Chloride Symporters" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (wakehealth.edu)
  • A subclass of symporters that specifically transport SODIUM CHLORIDE and POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process. (wakehealth.edu)
  • This graph shows the total number of publications written about "Sodium-Potassium-Chloride Symporters" by people in this website by year, and whether "Sodium-Potassium-Chloride Symporters" was a major or minor topic of these publications. (wakehealth.edu)
  • Below are the most recent publications written about "Sodium-Potassium-Chloride Symporters" by people in Profiles. (wakehealth.edu)
  • A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. (childrensmercy.org)
  • Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. (musc.edu)
  • This gene provides instructions for making a protein called the type IIb sodium-phosphate cotransporter, which plays a role in the regulation of phosphate levels (phosphate homeostasis). (medlineplus.gov)
  • In view of the sheer breadth of influence of this mineral, the fact that phosphate homeostasis is a highly regulated process is not surprising. (medscape.com)
  • Razzaque MS. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player. (medscape.com)
  • Vitamin D is a hormone regulating not only calcium and phosphate homeostasis but also, at the same time, exerting many other extraskeletal functions via genomic effects (gene transcription) and probably by non-genomic effects as well. (karger.com)
  • Impairment of the capability of the kidney to produce and reuptake enough calcitriol and therefore maintain vitamin D, phosphate, and calcium homeostasis is one of the principal pathophysiological components of metabolic bone disease in CKD. (karger.com)
  • Renal tubular reabsorption of phosphate is critical to the maintenance of phosphate homeostasis in mammals. (thermofisher.com)
  • Also, significant discoveries including new embryological molecular genetic transcription factors, the role of active placental mineral transport, and hormone regulation factors have changed the understanding of calcium and phosphate homeostasis in the fetus and the newborn. (frontiersin.org)
  • 2. The regulation of sodium/phosphate cotransporter activity in the renal tubules is the primary mechanism by which phosphate homeostasis is maintained. (frontiersin.org)
  • Drosophila transmembrane protein 214 (dTMEM214) regulates midgut glucose uptake and systemic glucose homeostasis. (ouhsc.edu)
  • Sodium-dependent phosphate transport protein 2C is a protein that in humans is encoded by the SLC34A3 gene. (wikipedia.org)
  • This gene is correlated closely with SLC34A1, an analogue sodium phosphate cotransporter protein. (wikipedia.org)
  • SLC34A2 gene mutations are thought to impair the activity of the type IIb sodium-phosphate cotransporter, resulting in the accumulation of phosphate in the alveoli. (medlineplus.gov)
  • X-linked hypophosphatemic rickets and autosomal recessive hypophosphatemic rickets are the result of mutations in PHEX (a phosphate-regulating gene with homologies to endopeptidases on the X chromosome) and dentin matrix protein 1 ( DMP1 ), respectively. (medscape.com)
  • However, renal expression of the sodium/phosphate cotransporter gene, NPT2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate. (thermofisher.com)
  • The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. (caslab.com)
  • 2016). Characterizing and evaluating the expression of the type IIb sodium-dependent phosphate cotransporter (slc34a2) gene and its potential influence on phosphorus utilization efficiency in yellow catfish (Pelteobagrus fulvidraco). (tcdb.org)
  • XLH is considered to be a systemic disorder, from mutation of the phosphate-regulating gene homologous to endopeptidases on the X chromosome ( PHEX ). (medscape.com)
  • The WNK4 gene provides instructions for making a protein that plays a role in blood pressure regulation by helping control the amount of sodium and potassium in the body. (medlineplus.gov)
  • Several sodium-coupled transport proteins have been identified that enable intracellular uptake of phosphate by taking advantage of the steep extracellular-to-intracellular sodium gradient. (medscape.com)
  • Phosphate uptake is increased at lower pH. (caslab.com)
  • It is capable of transporting a variety organic anions and mediates sodium-independent uptake of bile in the liver. (nih.gov)
  • The identification of the transport proteins responsible for the uptake and the efflux of nucleosides and their metabolites enables the characterization of their vectorial transport and a better understanding of their absorption, distribution, and elimination. (chk1inhibitor.com)
  • Overview: Lactose utilization in GapMind is based on MetaCyc pathway lactose degradation II via 3'-ketolactose ( link ), pathway III via beta-galactosidase ( link ), or uptake by a PTS system followed by hydrolysis of lactose 6'-phosphate. (lbl.gov)
  • 2015). Identification of the First Sodium Binding Site of the Phosphate Cotransporter NaPi-IIa (SLC34A1). (tcdb.org)
  • Exposure of epithelial type II cells to halothane reduced the activity of sodium, potassium-adenosine triphosphatase, and amiloride-sensitive Na channels, whereas Na cotransporters were unchanged. (asahq.org)
  • The decrease in sodium, potassium-adenosine triphosphatase activity was maximal for 30 min of exposure and reached 50, 42, and 56% for halothane concentrations of 1, 2, and 4%, respectively, and did not change for longer exposure times. (asahq.org)
  • Sodium, potassium-adenosine triphosphatase, and amiloride-sensitive Na channel activities are impaired by halothane in alveolar type II cells in vitro. (asahq.org)
  • [1-3] Because of the hypnotic effects of these agents, attention has focused mainly on the central nervous system, and several studies have reported that halothane exposure depressed voltage-gated sodium (Na) channels and potassium (K) channels. (asahq.org)
  • The ability to concentrate urine declines early and is followed by decreases in ability to excrete excess phosphate, acid, and potassium. (msdmanuals.com)
  • The WNK4 protein regulates channels in the cell membrane that control the transport of sodium or potassium into and out of cells, which occurs primarily in the kidneys. (medlineplus.gov)
  • The WNK4 protein is able to promote sodium reabsorption and block potassium secretion. (medlineplus.gov)
  • The increase in WNK4 activity leads to increased sodium reabsorption and reduced potassium secretion, resulting in hypertension and hyperkalemia. (medlineplus.gov)
  • Title: Comparison of patient acceptance of sodium phosphate versus polyethylene glycol plus sodium picosulfate for colon cleansing in Japanese. (aablocks.com)
  • These conditions may result in failure of osteoid calcification (rickets) in children because of a disruption in the pathway of either vitamin D or phosphate metabolism. (medscape.com)
  • Causes of rickets related to phosphate deficiency are discussed in the article Hypophosphatemic Rickets . (medscape.com)
  • Hypophosphatemic rickets is a form of rickets that is characterized by low serum phosphate levels and resistance to treatment with ultraviolet radiation or vitamin D ingestion. (medscape.com)
  • Clinical laboratory evaluation of rickets begins with assessment of serum calcium, phosphate, and alkaline phosphatase levels. (medscape.com)
  • This disorder was initially called vitamin D resistant rickets, is now called hereditary hypophosphatemic rickets because the primary problem is phosphate wasting rather than true vitamin D resistance. (boneandspine.com)
  • 2017). Characterization of the isoforms of type IIb sodium-dependent phosphate cotransporter (Slc34a2) in yellow catfish, Pelteobagrus fulvidraco, and their vitamin D3-regulated expression under low-phosphate conditions. (tcdb.org)
  • The primary transport protein responsible for phosphate reabsorption in the kidney is the type II sodium-phosphate cotransporter (NPT2a) localized in the proximal tubule. (hindawi.com)
  • It is expressed primarily by renal epithelial cells and functions as a co-transporter of sodium and sulfate, to mediate sulfate reabsorption in the kidney. (nih.gov)
  • It is an autosomal recessive disease and is associated with high levels of vitamin D. It is caused by genetic mutations of the renal type 2c sodium-phosphate cotransporter. (boneandspine.com)
  • The mutations involved in this condition change single protein building blocks (amino acids) in the WNK4 protein. (medlineplus.gov)
  • Phosphate transporters: a tale of two solute carrier families. (medscape.com)
  • Human concentrative nucleoside transporters (hCNTs/SLC28A) are known to mediate the transport of natural nucleosides and some nucleoside analogs into cells in a sodium-dependent SRT1720 chemical structure and unidirectional manner. (chk1inhibitor.com)
  • Phosphate is a predominantly intracellular anion with a concentration of approximately 100 mmol/L, although determination of the precise intracellular concentration has been difficult. (medscape.com)
  • however, because the intracellular concentration of phosphate is greater than the extracellular concentration, phosphate entry into cells requires a facilitated transport process. (medscape.com)
  • Study of these refractory cases revealed low serum phosphate concentration as a common factor. (medscape.com)
  • [ 5 , 6 ] However, lowered serum phosphate levels correlated with an equal degree of renal tubular reduction of tubular time of maximal concentration (T max ) of phosphate in both sexes, pointing to an additional factor in the creation of the bone disease in affected males. (medscape.com)
  • Variations in serum protein alter proportionately the concentration of the protein-bound and total serum calcium. (abdominalkey.com)
  • An increase in serum albumin concentration of 1 g/dL increases protein-bound calcium by 0.8 mg/dL, whereas an increase of 1 g/dL of globulin increases protein-bound calcium by 0.16 mg/dL. (abdominalkey.com)
  • Marked changes in serum sodium concentration also affect the protein binding of calcium. (abdominalkey.com)
  • Passive and active transport of bone-minerals occurs across the placenta to achieve higher fetal concentration of calcium, phosphate, and magnesium compared to maternal levels. (frontiersin.org)
  • Thus, the plasma sodium concentration is typically normal, and hypervolemia is infrequent unless dietary intake of sodium or water is very restricted or excessive. (msdmanuals.com)
  • Sodium glucose cotransporter 2 (SGLT2) inhibitor, also known as dapagliflozin (Dapa) can be used to treat diabetes. (bvsalud.org)
  • Or, a PTS forms lactose 6'-phosphate and phosphogalactosidase (pbgal) forms galactose 6-phosphate and glucose. (lbl.gov)
  • Comment: Glucose can be taken up and then phosphorylated to glucose 6-phosphate by the kinase glk. (lbl.gov)
  • Or, glucose is oxidized to glucono-1,5-lactone in the periplasm (by gdh), hydrolyzed to gluconate (by gnl), oxidized to 2-ketogluconate (by gadh123), taken up by kguT, phosphorylated to 2-dehydro-6-phosphogluconate (by kguK), reduced to gluconate 6-phosphate (by kguD), dehydrated by edd to 2-dehydro-3-deoxy-gluconate 6-phosphate, and cleaved by aldolase eda to pyruvate and D-glyceraldehyde 3-phosphate. (lbl.gov)
  • Comment: In the Leloir pathway, galactokinase (galK) forms galactose 1-phosphate, a uridyltransferase (galT) uses glucose 1-phosphate to form UDP-galactose, an epimerase (galE) forms UDP-glucose, and this is converted to glucose 1-phosphate by the same uridyltransferase. (lbl.gov)
  • Physicians now recognize that zinc supplementation can reduce the incidence and severity of diarrheal disease, and an ORS of reduced osmolarity (i.e., proportionally reduced concentrations of sodium and glucose) has been developed for global use. (cdc.gov)
  • Low phosphate and high alkaline phosphatase levels characterize most of the disorders. (medscape.com)
  • Bone as a source of FGF23: regulation by phosphate? (medscape.com)
  • Lammoglia JJ, Mericq V. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. (medscape.com)
  • Major phosphaturic hormones that regulate renal phosphate handling are PTH and FGF23. (frontiersin.org)
  • FGF23 is known to act on the kidney to cause increased phosphate excretion and decreased alpha-1 hydroxylase activity. (boneandspine.com)
  • The mutant protein is resistant to proteases and leads to an increase in serum FGF23. (boneandspine.com)
  • Laboratory evaluation was notable for persistent hypophosphatemia due to urinary phosphate wasting, low to low-normal 1,25-dihydroxyvitamin D, elevated alkaline phosphatase and elevated fibroblast growth factor 23 (FGF23). (biomedcentral.com)
  • Perilipin 5 (PLIN5) is a lipid-droplet-associated protein that coordinates intracellular lipolysis in highly oxidative tissues and is thought to regulate lipid metabolism in response to phosphorylation by protein kinase A (PKA). (uci.edu)
  • AE1 and NBCe1), and (iii) may provide sites for regulation of transporter function via protein kinase A phosphorylation (e.g. (tcdb.org)
  • The WNK4 protein acts as a kinase, which is an enzyme that changes the activity of other proteins by adding a cluster of oxygen and phosphorus atoms (a phosphate group) at specific positions. (medlineplus.gov)
  • The transgenic mice expressing human FGF-23 reproduced the common clinical features of these diseases such as hypophosphatemia probably due to increased renal phosphate wasting, inappropriately low serum 1,25-dihydroxyvitamin D level, and rachitic bone. (nih.gov)
  • Hypophosphatemia is defined as a serum phosphate level of less than 2.5 mg/dL (0.8 mmol/L) in adults. (medscape.com)
  • Tumor-induced osteomalacia (TIO) is a rare, acquired paraneoplastic disorder characterized by a renal phosphate leak leading to hypophosphatemia and deranged bone turnover. (hindawi.com)
  • The renal phosphate leak manifests itself in hypophosphatemia. (hindawi.com)
  • Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mujtations in the type 2a sodium-phosphate cotransporter. (medscape.com)
  • FLIM-FRET analysis of protein-protein interactions showed that PLIN5 S155 phosphorylation regulates PLIN5 interaction with adipose triglyceride lipase at the lipid droplet, but not with α-β hydrolase domain-containing 5. (uci.edu)
  • Comment: The tagatose 6-phosphate pathway involves the isomerization of galactose 6-phosphate to tagatose-6-phosphate (by lacAB), phosphorylation to tagatose 1,6-bisphosphate (by lacC), and an aldolase. (lbl.gov)
  • Gamba G. Regulation of the renal Na+-Cl- cotransporter by phosphorylation and ubiquitylation. (medlineplus.gov)
  • The addition and deletion of phosphate groups to enzymes and proteins are common mechanisms for the regulation of their activity. (medscape.com)
  • Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. (univ-paris5.fr)
  • 2007). These proteins are important for the regulation of intracellular pH (pH i ) and play crucial roles in the epithelial absorption of HCO 3 - (e.g., in the renal proximal tubule) and secretion of HCO 3 - (e.g., in the pancreatic duct). (tcdb.org)
  • High circulating FGF-23 levels produce renal phosphate wasting through the downregulation of NPT2a [ 2 , 3 , 9 ]. (hindawi.com)
  • Identification of an RNA-binding protein that is phosphorylated by PTH and potentially mediates PTH-induced destabilization of Npt2a mRNA. (univ-paris5.fr)
  • Parathyroid hormone (PTH) decreases sodium-phosphate cotransporter type IIa (NpT2a) mRNA stability. (univ-paris5.fr)
  • In TIO most tumors overexpress the protein fibroblast growth factor-23 (FGF-23) inhibiting renal phosphate reabsorption in the proximal tubules and acting as a phosphaturic factor [ 1 , 3 , 11 ]. (hindawi.com)
  • Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. (medscape.com)
  • The bulk of total body phosphate resides in bone as part of the mineralized extracellular matrix. (medscape.com)
  • Approximately 300 mg of phosphate per day enters and exits bone tissue. (medscape.com)
  • Excessive losses or failure to add phosphate to bone leads to osteomalacia. (medscape.com)
  • Matrix extracellular phosphoglycoprotein (MEPE) [ 12 ] and frizzled related protein-4 (FRP-4) have emerged as candidate mediators of the bone-renal pathophysiology as well but are rarely described in literature, so far [ 11 , 12 ]. (hindawi.com)
  • The bone minerals calcium, phosphate and magnesium are all maintained at higher concentrations in utero to achieve adequate bone accretion. (frontiersin.org)
  • Hyponatremia increases, whereas hypernatremia decreases protein-bound calcium. (abdominalkey.com)
  • Changes in pH also affect protein-bound calcium, and an increase or decrease of 0.1 pH increases or decreases protein-bound calcium by 0.12 mg/dL. (abdominalkey.com)
  • NPT2 is an integral membrane protein expressed in kidney and lung. (thermofisher.com)
  • Sodium channels help transport sodium into specialized kidney cells, which then transfer it into the blood. (medlineplus.gov)
  • Phosphate bonds of adenosine triphosphate (ATP) carry the energy required for all cellular functions. (medscape.com)
  • The pathway is driven by hydrolysis of the high-energy thioester bond of acetyl CoA and the terminal phosphate bond of adenosine triphosphate. (pharmacy180.com)
  • Structure-function relations of the first and fourth extracellular linkers of the type IIa Na+/Pi cotransporter: II. (wikipedia.org)
  • or a shift of phosphate from the extracellular to the intracellular space. (medscape.com)
  • This process depends on adequate levels of ionized calcium and phosphate in the extracellular fluid. (medscape.com)
  • 2004). Structure-function relations of the first and fourth predicted extracellular linkers of the type IIa Na + /Pi cotransporter: I. Cysteine scanning mutagenesis. (tcdb.org)
  • One mechanism is the binding of an extracellular ligand to a transmembrane G-protein-coupled receptor (GPCR). (pancreapedia.org)
  • The receptor protein has seven transmembrane α-helices connected by alternating cytosolic and extracellular loops. (pancreapedia.org)
  • The ligand-binding site is in the extracellular domain and the cytosolic domain has a heterotrimeric G protein-binding site (127). (pancreapedia.org)
  • Hyperparathyroidism may develop due to oral phosphate supplementation. (boneandspine.com)
  • Calculated tubular maximum for phosphate corrected for glomerular filtration rate (TmP/GFR) of 1.31 mg/dL (normal range 2.5 to 4.2 mg/dL) confirmed renal phosphate wasting (Table 2 ). (biomedcentral.com)
  • The renal phosphate wasting in the transgenic mice was accompanied by the reduced expression of sodium phosphate cotransporter type IIa in renal proximal tubules. (nih.gov)
  • The renal Na(+)/P(i) cotransporter NPT2 is expressed in the brush border membrane (BBM) of proximal tubular cells. (thermofisher.com)
  • Filtered phosphate, not reabsorbed in the proximal tubule, becomes concentrated in the thick descending limb of loop of Henle, due to water retrieval. (medscape.com)
  • Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS. (uchicago.edu)
  • In addition to serum phosphate studies, serum calcium and magnesium studies can be helpful for identifying underlying causes. (medscape.com)
  • Total serum calcium is divisible into protein-bound and ultrafiltrable (diffusible) calcium ( Fig. 6-1 ). (abdominalkey.com)
  • Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. (medscape.com)
  • Title: Budget-impact model for colonoscopy cost calculation and comparison between 2 litre PEG+ASC and sodium picosulphate with magnesium citrate or sodium phosphate oral bowel cleansing agents. (aablocks.com)
  • Although this protein can be found in several organs and tissues in the body, it is located mainly in the lungs, specifically in cells in the alveoli called alveolar type II cells. (medlineplus.gov)
  • Research suggests that the type IIb sodium-phosphate cotransporter normally helps clear this phosphate. (medlineplus.gov)
  • In addition to synthesizing surfactant, alveolar type II cells actively transport sodium (Na) from the alveolar space to the interstitium. (asahq.org)
  • 2012). Functional Interaction between CFTR and the Sodium-Phosphate Co-Transport Type 2a in Xenopus laevis Oocytes. (tcdb.org)
  • 2000). Molecular determinants of pH sensitivity of the type IIa Na/P(i) cotransporter. (tcdb.org)
  • For tumors that cannot be located, medical treatment with phosphate supplements and active vitamin D (calcitriol or alpha calcitriol) is a therapeutic option [ 9 ]. (hindawi.com)
  • Also, urinary loss of both vitamin D and vitamin D binding protein (VDBP) has been reported in these individuals. (karger.com)
  • Vitamin C, for example, is absorbed almost exclusively in the small intestine and requires sodium-dependent vitamin C co-transporter (SVCTs) proteins. (austinootropics.com)
  • Without these proteins, Vitamin C isn't absorbed. (austinootropics.com)
  • The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. (medscape.com)
  • Most often it is caused by long-term, relatively low phosphate intake in the setting of a sudden increase in intracellular phosphate requirements. (medscape.com)
  • Most intracellular phosphate is either complexed or bound to proteins and lipids. (medscape.com)
  • The animal AE proteins consist of homodimeric complexes of integral membrane proteins that vary in size from about 900 amino acyl residues to about 1250 residues. (tcdb.org)
  • The alterations to the WNK4 protein impair its breakdown, resulting in higher than normal levels of WNK4 protein and elevated WNK4 activity. (medlineplus.gov)
  • Organic Anion Transport Protein 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (ucdenver.edu)
  • Below are the most recent publications written about "Organic Anion Transport Protein 1" by people in Profiles. (ucdenver.edu)
  • These cells produce and recycle surfactant, which is a mixture of certain phosphate-containing fats (called phospholipids) and proteins that lines the lung tissue and makes breathing easy. (medlineplus.gov)
  • Advanced glycation end products and S100 proteins interact with the receptor for advanced glycation end products (RAGE). (jostchemical.com)
  • DEC-205 (CD205), a member of the macrophage mannose receptor protein family, is the prototypic endocytic receptor of dendritic cells, whose ligands include phosphorothioated cytosine-guanosine (CpG) oligonucleotides, a motif often seen in bacterial or viral DNA. (uci.edu)
  • Here we describe the 3.2 Å cryo-EM structure of human DEC-205, thereby illuminating the structure of the mannose receptor protein family. (uci.edu)
  • Despite a diminishing GFR, sodium and water balance is well-maintained by increased fractional excretion of sodium in urine and a normal response to thirst. (msdmanuals.com)
  • The well-characterized mammalian proteins are found in renal (IIa isoform) and intestinal (IIb isoform) brush border membranes and are about 640 amino acyl residues long with 8-12 putative TMSs. (tcdb.org)
  • In addition, a renal tubular defect that reduces reabsorption may alter phosphate metabolism. (medscape.com)
  • Title: Citrate, not phosphate, can dissolve calcium oxalate monohydrate crystals and detach these crystals from renal tubular cells. (aablocks.com)